SampleID,gdc_file_uuid,filename,age_at_diagnosis,aliquot_uuid,case_uuid,days_to_death,disease_type,ethnicity,experimental_strategy,gender,investigation,platform,primary_site,race,reference_genome,sample_type,sample_uuid,vital_status,tissue_source_site_label,data_submitting_center_label,country_of_sample_procurement,histological_diagnosis_label,pathologic_t_label,pathologic_n_label,pathologic_stage_label,icd03_histology_label,icd03_histology_site,icd10,portion_is_ffpe,new_tumor_event_after_initial_trtmt,primary_therapy_outcome_success_label,portion_weight,aliquot_concentration,analyte_A260A280Ratio,analyte_amount,analyte_type_label,radiation_therapy_code_label,radiation_therapy_site_label,radiation_therapy_type_label,year_of_diagnosis,vital_status_label
s1039,2C62A6EB-169D-4B26-A202-8E92DCBB2512,UNCID_2375184.2f0e0b9f-2660-4f2a-b6f3-e5c5476238ca.sorted_genome_alignments.bam,34,2F0E0B9F-2660-4F2A-B6F3-E5C5476238CA,e9016544-de18-4df8-82ee-bc0a88f935c6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,45227827-B8C8-496A-B7C9-3AAC23F99C28,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.91,27.74,RNA,,,,,Alive
s914,E2CBA7F8-E3EA-4450-A859-721C4542D557,UNCID_2357553.f813cdc6-f6e5-4d53-a9b3-841b091aea32.sorted_genome_alignments.bam,31,F813CDC6-F6E5-4D53-A9B3-841B091AEA32,be7d999b-9725-4bf0-b337-cdc3ed55f05f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,2950AB92-F806-4CC6-B81E-4352973DC8AA,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.88,34.78,RNA,,,,,Alive
s978,CE61A29A-B78F-404F-975F-E9CDF234FD1E,UNCID_2367239.534e617a-bcbe-4e5e-b4e9-4b979f6dfa54.sorted_genome_alignments.bam,46,534E617A-BCBE-4E5E-B4E9-4B979F6DFA54,0779af6b-7908-440a-9dcb-283bd95f3305,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,0E79D829-AB78-4D16-83FD-55654DCA7711,Alive,St. Joseph's Hospital (AZ),University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-93,C76.0,C76.0,NO,NO,Complete Remission/Response,30.0,0.17,2.0,17.98,RNA,,,,,Alive
s1018,C3E2A1DD-29D4-4FA7-ABC2-A6E14D1C96F5,UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments.bam,66,E9566249-B898-4DA6-AE19-360B3C71AA20,9d6e8692-ab14-414f-a5fd-556b9d62fe34,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,Not available,HG19,Primary Tumor,7E143858-0F6A-4B52-B5DA-E366ABF2E91C,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.86,34.01,RNA,,,,,Alive
s1011,A11C2023-32B1-4DEC-92F0-D5B0931F6294,UNCID_2367037.270574c4-6a67-4639-9fd8-7734044ac317.sorted_genome_alignments.bam,27,270574C4-6A67-4639-9FD8-7734044AC317,74d1a38b-0ed6-482a-a9d8-bb9e8cd2253d,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A55B3479-14E7-4C6A-94B3-711FC7C4BECF,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.87,18.38,RNA,,,,,Alive
s1084,3829774A-75C5-433D-8311-8C2641EE39DC,UNCID_2384083.a30dd71f-039e-4713-995d-3237b7b5cbe3.sorted_genome_alignments.bam,30,A30DD71F-039E-4713-995D-3237B7B5CBE3,1a05a84d-e475-43b8-8494-3cf8c2a64d2c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,BDA16432-028C-41A9-9B3F-68F168174D52,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.8,66.3,RNA,,,,,Alive
s1060,BB175A01-D464-4669-B804-51C15A1022FE,UNCID_2375254.b2dc2165-2964-4aaf-84ab-fa8c56b94ac1.sorted_genome_alignments.bam,61,B2DC2165-2964-4AAF-84AB-FA8C56B94AC1,cb96fd6f-322e-4bb1-9d20-aae21d124308,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,A9EC3070-1EAB-4503-A406-A51FE3EB10FD,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C75.5,C75.5,NO,NO,Complete Remission/Response,30.0,0.18,1.93,31.85,RNA,,,,,Alive
s944,C10646FA-3569-4EAA-9279-0241C0FB4D64,UNCID_2362079.2a497089-5263-4338-adac-9a8f82897aae.sorted_genome_alignments.bam,44,2A497089-5263-4338-ADAC-9A8F82897AAE,82d46f15-8e1b-4782-bd3a-6cfcda116431,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,9AD0C403-3B57-4DF4-8739-B47AE7D1B092,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.9,27.69,RNA,,,,,Alive
s1031,F29A475C-8BA7-46D0-A137-97750B2F5653,UNCID_2378077.a75fa2d5-0c31-45a7-831a-357443c12483.sorted_genome_alignments.bam,40,A75FA2D5-0C31-45A7-831A-357443C12483,766c325b-404a-48c3-ba6b-5e17daff83be,309.0,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,20A54B14-FBF4-4667-909B-FC0AC07827E5,Dead,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Progressive Disease,20.0,0.17,1.75,13.94,RNA,,,,,Dead
s1092,EF0E615D-3E1E-4C00-BC4A-AB7DBF75D560,UNCID_2380756.0d74c61e-34fe-4345-bc5e-4bf32464d0a6.sorted_genome_alignments.bam,46,0D74C61E-34FE-4345-BC5E-4BF32464D0A6,ee01b7b0-db62-48bf-804f-617735d234e1,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,437A1184-BA17-433E-AA34-7A9E809EC422,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.96,37.04,RNA,,,,,Alive
s1000,7FA01974-CA52-4C15-8462-9EB17D8C6C6E,UNCID_2369451.e8d3931d-0611-4c2d-8c8c-1ef12b00a5e1.sorted_genome_alignments.bam,63,E8D3931D-0611-4C2D-8C8C-1EF12B00A5E1,6b8ea229-a96d-4632-add9-18996f59db81,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,701B4E30-6803-430E-BBEE-44ABD8784E0E,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,35.01,RNA,,,,,Alive
s958,DCB7512D-D293-4578-96EF-E0C8F3DBF9CE,UNCID_2363697.e5cd9627-d938-43e8-ab5a-7e61ca1a887a.sorted_genome_alignments.bam,44,E5CD9627-D938-43E8-AB5A-7E61CA1A887A,e90e83ef-6b0d-439b-a1c2-8d8dd3ebd090,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,6E9CDE8F-229D-43AA-937C-6B454E8AB8D9,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,YES,Progressive Disease,30.0,0.18,1.96,47.66,RNA,,,,,Alive
s1014,9B9DC9CF-F576-4DE1-8EE3-B563CBE13C69,UNCID_2369551.786e4975-18e4-473c-97bf-2f5a57f4cd1d.sorted_genome_alignments.bam,31,786E4975-18E4-473C-97BF-2F5A57F4CD1D,f94f3c0e-19a5-4a31-870c-e04bb0f3efcf,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,Not available,HG19,Primary Tumor,6BF2FD8D-2F86-4FAF-9EBD-6346F750D24B,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.87,35.57,RNA,,,,,Alive
s937,8124A08E-F2A2-4D2B-ADFA-7BB4E809952B,UNCID_2366729.f4051cc1-b08f-4657-aeea-5b71394a3fd6.sorted_genome_alignments.bam,56,F4051CC1-B08F-4657-AEEA-5B71394A3FD6,7cd44e72-55e4-4af9-b3d9-9a5d0266859a,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,2E74620A-22B6-4A26-BC7F-6D75DF8D7B70,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.85,31.0,RNA,,,,,Alive
s1004,6C167FC0-90EC-45F0-BEA7-93A6EF74D502,UNCID_2373586.5802832e-0c7c-4ca1-b556-906a20be861e.sorted_genome_alignments.bam,64,5802832E-0C7C-4CA1-B556-906A20BE861E,46e207c8-bdeb-468e-a34e-01cb54085f6b,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1E425E91-CC5C-4BDC-BD95-0F01B43201F6,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.96,48.39,RNA,,,,,Alive
s934,45912828-4712-4A17-BADF-10259F3EC628,UNCID_2362245.bcaa4853-de3c-479c-83ac-008181336cba.sorted_genome_alignments.bam,43,BCAA4853-DE3C-479C-83AC-008181336CBA,168b0d62-ee55-4911-b462-d7902824298d,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,FF304E13-8DDE-4EB6-815F-A81EC3C4A570,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.8,29.62,RNA,,,,,Alive
s1064,6BFB085F-AFEF-492B-AF41-7AC94976CC12,UNCID_2378265.7b6a1a09-716e-4382-88b3-e36dcfadcba7.sorted_genome_alignments.bam,47,7B6A1A09-716E-4382-88B3-E36DCFADCBA7,ba65b478-65d0-4c9a-a2c2-d32b29a1a9c4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,EFB99059-EC9A-46F4-A38E-96393953CFDA,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-93,C38.3,C38.3,NO,YES,Complete Remission/Response,30.0,0.18,1.92,42.53,RNA,ABE12C9A-DBDF-48BC-A3E1-B8B203DECDC8,Distant site,Systemic,,Alive
s1050,15A02FD2-EF8F-4073-B0ED-E559F4B24AC0,UNCID_2378218.0172416d-e694-4e99-bd93-fa6ac04dda81.sorted_genome_alignments.bam,35,0172416D-E694-4E99-BD93-FA6AC04DDA81,5a92887a-c367-4fa7-a696-23e70de033c7,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,CC42C317-ED34-4E21-BD0A-F4DD78CDE167,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.16,1.82,48.3,RNA,,,,,Alive
s1075,B343437A-0C35-445C-A24D-2480AFF7689F,UNCID_2380807.e69bb6e7-9c70-4eb0-ab2a-6921dfff0c38.sorted_genome_alignments.bam,55,E69BB6E7-9C70-4EB0-AB2A-6921DFFF0C38,40ff83f1-2255-47b8-ae2d-8bfd4df4dc29,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,32274771-5814-44F0-970B-9649842F9EED,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.92,52.76,RNA,,,,,Alive
s1085,8FE88E26-797A-4097-9535-C19808BDB721,UNCID_2384019.4f8be51b-2aea-44fe-b754-82262225d991.sorted_genome_alignments.bam,59,4F8BE51B-2AEA-44FE-B754-82262225D991,909d5bf5-2ae1-4801-b717-f379a7e26e1d,596.0,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E45B6EC8-B82E-44A1-A732-AFC75317A85A,Dead,Erasmus MC,University of North Carolina,Italy,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.83,20.95,RNA,,,,,Dead
s1020,BD861414-4863-45D1-B057-07E140BA1E57,UNCID_2369378.6d58864b-b895-4908-bf83-3e7535f946bc.sorted_genome_alignments.bam,46,6D58864B-B895-4908-BF83-3E7535F946BC,74fdffa2-d0a8-4fe3-b996-0e8d81436516,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,426329D8-35D7-4B64-B7DD-BFB06D1AC0F6,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,18.17,RNA,,,,,Alive
s933,B6FE27C8-0379-4EB3-9D01-70371198F774,UNCID_2363002.419325de-c6ad-4d9f-a470-4c64431ba335.sorted_genome_alignments.bam,24,419325DE-C6AD-4D9F-A470-4C64431BA335,5822a2fd-708c-4180-abed-a8053edc0429,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,2CF525C1-FCD3-49C7-B829-F349965E8D27,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,20.0,0.17,1.8,15.28,RNA,,,,,Alive
s1048,90BEB9C3-7CEB-4AC9-8BFF-2933FBECC4C1,UNCID_2375123.e1de4889-03a7-4e3b-8759-1eb9e087725e.sorted_genome_alignments.bam,48,E1DE4889-03A7-4E3B-8759-1EB9E087725E,c6f5ec07-84bb-4868-be01-8fe8c7ce6999,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,E77BCE48-E067-41BD-BC13-50D49A12B942,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.0,C74.0,NO,YES,Complete Remission/Response,30.0,0.18,1.91,44.18,RNA,,,,,Alive
s1035,2161680F-ADC5-4888-ABE9-0935671D6D95,UNCID_2378140.467b29ec-2529-4553-85d7-b64107791eb5.sorted_genome_alignments.bam,40,467B29EC-2529-4553-85D7-B64107791EB5,9dfb14b5-d045-4047-8a09-0a8a9d79114c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CE8FD963-7E10-4080-87E1-44402B30496F,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.94,33.94,RNA,,,,,Alive
s1061,8367F7B6-0FD7-4225-9C7E-4E52F26BE9D9,UNCID_2373890.5d88a24f-8626-4f65-b034-f85282eef80e.sorted_genome_alignments.bam,35,5D88A24F-8626-4F65-B034-F85282EEF80E,4afdc661-7127-4c2e-9b66-4b0313772280,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,F693094E-9775-408E-A531-80787A6DC131,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.81,8.74,RNA,,,,,Alive
s1002,4DF60A30-6446-4EBE-BD5C-152011209436,UNCID_2366898.0275d061-9d9e-4f3e-9fcd-44566dd9ccd9.sorted_genome_alignments.bam,46,0275D061-9D9E-4F3E-9FCD-44566DD9CCD9,ef1e58d9-2f85-49a7-b50b-df312e544319,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,D2C79B8F-2476-458F-9533-AC1136AC4AA2,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,25.08,RNA,,,,,Alive
s931,4688498F-3144-4C4D-BDC1-9D12F6FE84D2,UNCID_2361944.187074a8-21c9-46fb-9d36-7968d5a87314.sorted_genome_alignments.bam,31,187074A8-21C9-46FB-9D36-7968D5A87314,c7c3dec8-0251-4396-9d79-9dd28d70ab3d,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,3D331841-B4EF-4311-801C-A3E2EAACC2E9,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.86,16.02,RNA,,,,,Alive
s1078,65936058-1004-4789-80C4-EA901F348800,UNCID_2382152.961e1a4e-9e7f-4d2a-a090-50d9457a218b.sorted_genome_alignments.bam,54,961E1A4E-9E7F-4D2A-A090-50D9457A218B,9ea29c7c-7e10-433d-a5b4-60ce9a48beac,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,925C665F-26C1-4A72-9533-0295BCB8381B,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.9,10.7,RNA,,,,,Alive
s975,AF2DAA8E-BE20-48F9-B2B1-C373AFED1606,UNCID_2369511.faa89b72-ce59-4f2a-b992-72af20963202.sorted_genome_alignments.bam,44,FAA89B72-CE59-4F2A-B992-72AF20963202,c4ed3216-6db9-424c-94f5-26c2fc0e95ee,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,2508B8CD-ECBE-400A-9D8A-CBAB546CDF3B,Alive,University of Minnesota,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.17,1.87,48.39,RNA,,,,,Alive
s1047,E2C964DE-2C04-4E6E-B0C7-80609C907D79,UNCID_2375208.1f96103c-6baa-4ef0-8134-a34af346295b.sorted_genome_alignments.bam,19,1F96103C-6BAA-4EF0-8134-A34AF346295B,be08b718-93ce-476a-99f6-4239c7f0bbfa,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E363E6F6-DAA8-4423-BB7C-11E00DB4D550,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.16,1.84,16.85,RNA,,,,,Alive
s994,90E8591F-3368-407B-A96F-D39BCE9BBBB0,UNCID_2369780.ff0535f4-481d-479e-aa3a-715124d9e1d7.sorted_genome_alignments.bam,39,FF0535F4-481D-479E-AA3A-715124D9E1D7,9cb0dea2-8c02-48c1-8217-0529cc57addc,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,1A0D2BEA-3F45-4AC5-9017-F530E6E426B1,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-91,C49.3,C49.3,NO,NO,Complete Remission/Response,10.0,0.16,1.86,8.44,RNA,,,,,Alive
s916,D57A1E1E-C657-4DEA-A02E-23C45801C345,UNCID_2354183.f9d224fb-5f3b-4261-8625-29c117b0b56c.sorted_genome_alignments.bam,21,F9D224FB-5F3B-4261-8625-29C117B0B56C,28fffbe3-2b11-42cd-89fc-d06a546cf9a0,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,51FDBDEF-E2FB-43FE-8020-276BA3F70AE2,Alive,Translational Genomics Research Institute,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.89,17.97,RNA,,,,,Alive
s1095,F9A3C4C9-AB4D-4764-8073-3047467B9719,UNCID_2388475.38344f50-9bf3-4386-8eeb-e8a79ca1ee8e.sorted_genome_alignments.bam,44,38344F50-9BF3-4386-8EEB-E8A79CA1EE8E,4dc21807-d51c-47ac-8eb5-0cedd010fa97,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CB39A103-750D-49BE-B75A-01612487AAEE,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Not available,30.0,0.17,1.81,37.3,RNA,,,,,Alive
s932,78CEB545-190D-40C1-8EC7-A1C68AE4FE14,UNCID_2362519.6b234ea7-7c91-4880-92c6-12ebc5520c90.sorted_genome_alignments.bam,37,6B234EA7-7C91-4880-92C6-12EBC5520C90,5e1dbef9-c226-4464-9c08-bcf9e75e364f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C0731097-1A1B-4AAB-B7F0-805790795802,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.81,31.09,RNA,,,,,Alive
s940,BD291B5D-60FD-409B-AB77-ACF3E178D624,UNCID_2362407.08ed2b94-bffb-4814-9b9c-cbed531cd1a1.sorted_genome_alignments.bam,51,08ED2B94-BFFB-4814-9B9C-CBED531CD1A1,ecd41483-3c0d-4181-a6bf-14769f7f7394,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B3C800D8-7923-4757-8DF0-3E54F58D4BA0,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.86,22.94,RNA,,,,,Alive
s1045,0568E9E6-EE31-4C36-83B5-C9B488A5D559,UNCID_2378149.420ac635-2482-4a6d-ac4f-5c8dd7f82401.sorted_genome_alignments.bam,73,420AC635-2482-4A6D-AC4F-5C8DD7F82401,dea71f6d-cad5-4d4e-aa62-ac5f4c547135,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C2B0C923-F1D6-42EF-B921-69D712B6531B,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.92,44.69,RNA,,,,,Alive
s1067,0715268F-22DD-4E76-920C-0D26F5F03672,UNCID_2374064.d7a07593-9b26-4028-aa23-98d2b3e2f331.sorted_genome_alignments.bam,28,D7A07593-9B26-4028-AA23-98D2B3E2F331,be51b087-0861-4555-974d-457108608c36,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,6E598ABC-58CC-4639-BB67-D6F5C11D4598,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.87,41.88,RNA,,,,,Alive
s1083,8F1558AB-4FE5-4BED-89FE-DE5FCE3835AF,UNCID_2382122.c4fbc7f9-5a13-40bf-ae16-9d146d7f79b2.sorted_genome_alignments.bam,45,C4FBC7F9-5A13-40BF-AE16-9D146D7F79B2,a39ac229-60d2-42c2-9721-7e0894c0ae38,3563.0,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,BA8FB2B9-EEA9-450E-99D1-02CC25AA7C58,Dead,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,YES,Progressive Disease,30.0,0.18,1.86,29.81,RNA,8B76CFEF-A326-4DF9-AB63-FD4D50C93A22,Distant site,External,,Dead
s966,9CFD10A3-6801-4495-B5C2-E1AAA7333D4B,UNCID_2366790.2addf84e-ba23-45e5-beb1-99a8217d3c30.sorted_genome_alignments.bam,58,2ADDF84E-BA23-45E5-BEB1-99A8217D3C30,f49438a7-c5e5-47e7-bef4-5e6881a0732a,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,403D99AB-C672-4B3C-9842-E26E8234ACA6,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,39.39,RNA,,,,,Alive
s1040,E9B81D9B-5BFC-46CA-AD8F-B8290CE18424,UNCID_2374082.55ad376a-2d52-45b2-854e-1ea1c67765f6.sorted_genome_alignments.bam,20,55AD376A-2D52-45B2-854E-1EA1C67765F6,3b6b1088-662a-4a66-8134-97d385eb5ae9,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,41F5A681-2C3A-4154-8CCA-A23F0701D355,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,Mar-93,C48.0,C48.0,NO,YES,Progressive Disease,30.0,0.18,1.93,27.49,RNA,,,,,Alive
s924,58ECCC8F-8782-4CC1-88BF-8600E1AC2C6F,UNCID_2357944.47a386b5-7214-48b3-91fa-ce7101b8d662.sorted_genome_alignments.bam,41,47A386B5-7214-48B3-91FA-CE7101B8D662,f027a6b4-4007-4ba1-a2e8-3567b266bcf4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E25DC902-2945-4744-AC0F-C03197D393F3,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C76.1,C76.1,NO,NO,Complete Remission/Response,30.0,0.16,1.89,16.98,RNA,,,,,Alive
s942,9DCC67B5-A5B0-493B-9C4B-9A361BD19C2D,UNCID_2364294.f2550cd8-e489-42c3-be9d-31f765c15fcb.sorted_genome_alignments.bam,52,F2550CD8-E489-42C3-BE9D-31F765C15FCB,dc5c8c56-e3be-4649-8df5-622d497955ce,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4A5678CF-B834-4A4E-A84D-B38DC602AF77,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.15,1.87,19.11,RNA,,,,,Alive
s1089,3ADA5957-7F2B-4826-849C-581F1DBB6994,UNCID_2384033.b80146b3-ebce-461c-9c30-f089c7039828.sorted_genome_alignments.bam,67,B80146B3-EBCE-461C-9C30-F089C7039828,da094e20-df07-4efa-892c-33f4ac5c3056,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,BFF96B17-70A6-4477-9152-D1D41B3ADC70,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.92,39.31,RNA,,,,,Alive
s935,C32DF45B-240D-4B6F-8937-307A877CDCCB,UNCID_2362292.dc201a89-1126-41fb-b59c-34410890dbef.sorted_genome_alignments.bam,30,DC201A89-1126-41FB-B59C-34410890DBEF,4588181a-318c-431f-84d3-6688870e08ad,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,3DD90899-3C25-4128-AB36-9789A536387D,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.91,15.73,RNA,,,,,Alive
s1077,E82599FF-4E05-41C3-8DF2-D9172059E9B8,UNCID_2381197.b095864c-bcf7-41cc-b49f-a76b1adfe6d1.sorted_genome_alignments.bam,45,B095864C-BCF7-41CC-B49F-A76B1ADFE6D1,41ce2937-0bee-46d4-b08c-3fe74e262f93,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C34FBE41-9F61-4756-8AA4-766B6CC30DB4,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.76,29.63,RNA,,,,,Alive
s1013,CD9E7A66-CC62-44B8-A8C4-B28A85773A37,UNCID_2367134.dd851272-51a0-456c-87e6-b31dcdf4d36f.sorted_genome_alignments.bam,49,DD851272-51A0-456C-87E6-B31DCDF4D36F,3e69514f-78ea-4d70-97e6-12a9016e9bca,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,9A62A9B2-E87F-494B-9DE1-227B9108EF46,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.85,39.88,RNA,,,,,Alive
s983,AE11FBA8-D0EB-4132-A5D2-509E839415B6,UNCID_2373814.07771c8c-332b-4a93-bb47-10195f148957.sorted_genome_alignments.bam,27,07771C8C-332B-4A93-BB47-10195F148957,2337ed44-c455-4df7-91a3-b30da0e54da4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,BDDA4C01-744B-42E9-BEBB-65705DB11E58,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.98,56.54,RNA,,,,,Alive
s1032,40B01061-1318-4AEB-9190-56BAF5B1FB48,UNCID_2375378.6abbad6b-e297-4ee8-a037-68b9d9e13eb8.sorted_genome_alignments.bam,57,6ABBAD6B-E297-4EE8-A037-68B9D9E13EB8,1e9545a5-2bfa-41c1-b4c9-ac74608376ed,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,8C0F4AF2-14A5-4C90-903D-232C5E6C6EC3,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-80,C49.4,C49.4,NO,NO,Complete Remission/Response,30.0,0.16,1.98,28.04,RNA,,,,,Alive
s997,60E04830-8D0D-420E-BD3A-0DA166CFA546,UNCID_2370172.ed44bcc4-99b7-4308-8673-64797735fb5a.sorted_genome_alignments.bam,74,ED44BCC4-99B7-4308-8673-64797735FB5A,cc95f915-33e7-4c57-9e6b-4c0e2ba598b2,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1A0DDA9D-8DAD-4692-A9D5-75AC6E268D97,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.81,28.22,RNA,,,,,Alive
s957,2A3A3ECD-D2A9-422F-8828-C112D0506321,UNCID_2362442.5e413540-8945-45ce-a033-8901ee56eb7d.sorted_genome_alignments.bam,40,5E413540-8945-45CE-A033-8901EE56EB7D,d0ac8d96-9d78-4f4b-9fbe-1202631c70a5,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E8C67AF8-42CA-49FA-8609-054052EC2C49,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.17,1.87,23.67,RNA,,,,,Alive
s927,D6E6EC26-908D-4941-AF8E-BC8DDC4CBD14,UNCID_2357655.7c65b352-e682-4757-a1ee-4afc74a2d62d.sorted_genome_alignments.bam,50,7C65B352-E682-4757-A1EE-4AFC74A2D62D,e4d27efb-a05b-4903-8133-62ca12c7e4ed,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A4433A73-76F6-4708-93D7-AC32E0E13974,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C49.3,C49.3,NO,NO,Complete Remission/Response,10.0,0.17,1.88,8.4,RNA,,,,,Alive
s939,931FDB53-E262-48C8-AF54-E0951F036140,UNCID_2362329.ff30f911-6a2a-47ba-b348-0c0a637579f2.sorted_genome_alignments.bam,61,FF30F911-6A2A-47BA-B348-0C0A637579F2,d9a3a037-9a96-45a2-8801-f9f408d74523,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,22B604AD-F373-4F7D-9024-CFD0E079B75B,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.18,1.89,36.33,RNA,,,,,Alive
s1052,86C6F371-D1E1-42D4-8AEE-F1BD97545E18,UNCID_2378067.78959883-a07c-41e2-8002-6032b710e4b3.sorted_genome_alignments.bam,42,78959883-A07C-41E2-8002-6032B710E4B3,f59d5e25-1b13-436f-9630-6c550337a349,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1683BDA9-49EB-4937-9999-70E1FCCBA74C,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.96,58.89,RNA,,,,,Alive
s930,CE286149-3EB0-41D3-B2E8-2E29C0A13942,UNCID_2364376.a9efcdd6-eb6e-40c9-9bc2-0297d1ec8f6b.sorted_genome_alignments.bam,30,A9EFCDD6-EB6E-40C9-9BC2-0297D1EC8F6B,7a540d69-e0c5-4b6c-ad1e-6300ecda26c4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1EEF18F6-5C15-4174-A9B7-9626189EB2D6,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,20.0,0.17,1.94,15.08,RNA,,,,,Alive
s1033,CEB0AFBA-4AE6-408F-9F1C-40D0B9858B68,UNCID_2374140.d912e540-038b-4862-92d0-3af57d120cd6.sorted_genome_alignments.bam,42,D912E540-038B-4862-92D0-3AF57D120CD6,a9593c31-72d2-4d70-a64f-d2776bcb0367,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,B56B9CB7-5604-4C8D-ACF3-D227957FF670,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,34.1,RNA,,,,,Alive
s1003,4ED1C697-2DCD-4107-B6C7-0063802EF888,UNCID_2369614.aaa4291c-795b-4bca-aab5-6c0c795a7ef4.sorted_genome_alignments.bam,35,AAA4291C-795B-4BCA-AAB5-6C0C795A7EF4,222cc45f-bebf-41b0-ab56-0953d53f2bfa,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C9013BCD-65EE-4C09-91F7-DE2F81420A9A,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.86,14.18,RNA,,,,,Alive
s965,16DDD22B-4D93-4948-949C-9A64BDA3B4B6,UNCID_2366818.c8367fe4-687e-4f4d-8564-2d46d05e460d.sorted_genome_alignments.bam,43,C8367FE4-687E-4F4D-8564-2D46D05E460D,c0a56781-436e-48d6-8fe4-37a2f87679f2,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,87ED97C5-ABE6-4AE5-A51F-A001B85A89BA,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.9,32.26,RNA,,,,,Alive
s1028,AF935EAB-6DB2-414E-9E86-99DEBD4AC8DF,UNCID_2374012.4c81b542-cb70-4b53-850c-03a17237dfdf.sorted_genome_alignments.bam,30,4C81B542-CB70-4B53-850C-03A17237DFDF,323e134e-caa8-42b7-9114-78812e1196ea,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A10F9167-5875-42B3-9014-9BB2F07757AB,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.94,32.27,RNA,,,,,Alive
s985,87202D53-6D94-4ED6-8522-A2964513D514,UNCID_2369751.15419dae-0aa7-437b-8508-1078b88552fc.sorted_genome_alignments.bam,71,15419DAE-0AA7-437B-8508-1078B88552FC,ac5d4a1c-ee54-4f0e-8289-a546eead2750,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,255CDB3B-C67C-4B62-AABE-E0F50388513D,Alive,Cleveland Clinic Foundation,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.85,24.47,RNA,,,,,Alive
s955,70CC7713-699A-461D-B45B-55F520EF323F,UNCID_2362257.276a1e00-cf3a-4463-a97b-d544381219ea.sorted_genome_alignments.bam,35,276A1E00-CF3A-4463-A97B-D544381219EA,1a2e36dd-3e3b-493c-a075-4ca3acfe2207,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,900C51FA-F50E-4463-B51E-F541DC818D91,Alive,University of Pittsburgh,University of North Carolina,Afghanistan,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Not available,30.0,0.18,1.84,46.96,RNA,,,,,Alive
s1097,5997EC2A-B776-4FE4-8FCC-DDFDFFCF9426,UNCID_2389044.3fbe748d-9051-4835-a5ee-adfa379b1415.sorted_genome_alignments.bam,63,3FBE748D-9051-4835-A5EE-ADFA379B1415,79c6f3cd-f299-4283-b5ce-54ab41e0aeb5,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E11D0BD5-CE8F-4594-87EB-DAD4E0EAC33E,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.18,1.8,34.1,RNA,,,,,Alive
s980,AE1F37DB-FF6D-47BA-9FA5-66F9C2ECAFC8,UNCID_2369341.9393f6bc-5b3c-4cad-8141-8076f9d4ffce.sorted_genome_alignments.bam,32,9393F6BC-5B3C-4CAD-8141-8076F9D4FFCE,70b8a84e-47e3-47f9-b36c-646338695005,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,BF2F8C13-57F8-45F5-BBA6-768F3EE8B5BE,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.83,14.14,RNA,,,,,Alive
s1062,E381EFB7-AA49-4B63-BC6E-5E2FE2AF9049,UNCID_2373952.0a4fe787-7462-4fa2-9fd1-7424a966f541.sorted_genome_alignments.bam,76,0A4FE787-7462-4FA2-9FD1-7424A966F541,951a3ce0-fd36-44d8-9456-72d0d4c258a5,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,97B4FF05-1966-423D-AD6D-605279752CC7,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.9,50.43,RNA,,,,,Alive
s998,E4F91EB3-8907-4F23-A144-F25D49646CBE,UNCID_2370028.6459fde3-b0b0-4b97-bdb3-06ea4b9a3451.sorted_genome_alignments.bam,46,6459FDE3-B0B0-4B97-BDB3-06EA4B9A3451,8850ef47-bd16-459b-8aa6-d37f81d9b202,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,6830124E-25CA-4E67-88A4-2FAEEADDE796,Alive,Not available,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-80,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.17,1.9,46.36,RNA,,,,,Alive
s1096,5AC5B212-F1BF-4EE2-8D0D-8CADA3083F5F,UNCID_2388873.d1dd5b3b-40b8-4740-ba42-1fe4ba4e35d1.sorted_genome_alignments.bam,45,D1DD5B3B-40B8-4740-BA42-1FE4BA4E35D1,d932b05b-a832-491b-a376-7fa5f7354b74,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,B340CDDF-2E09-400A-BB66-7087F44E08B0,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.77,36.28,RNA,,,,,Alive
s1079,CCDAF97F-1F76-43E9-957B-D1354B1CB67E,UNCID_2380797.c2850229-e8a6-436a-9ed9-b8c6b101a0c9.sorted_genome_alignments.bam,36,C2850229-E8A6-436A-9ED9-B8C6B101A0C9,faf91ee3-3281-4f8e-8bdf-2fda22261010,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,6A21F1F0-BE6E-46A1-ACAD-32C1F9EEEC00,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.79,38.85,RNA,,,,,Alive
s1072,6A008426-1219-4528-BD5E-BE0D179211A6,UNCID_2378264.951535db-1e3a-436a-989f-52197336b6b6.sorted_genome_alignments.bam,61,951535DB-1E3A-436A-989F-52197336B6B6,f06855ed-b99f-4431-9009-9de6d83b64e1,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,66264AE1-0038-4664-BD31-554DA2095CA7,Alive,University of Pennsylvania,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C49.4,C49.4,NO,NO,Complete Remission/Response,30.0,0.18,1.84,26.5,RNA,,,,,Alive
s926,3B3131BC-F3D7-408B-942B-BEE84B9D9A9A,UNCID_2357518.e9f19ad6-67cb-469a-bce1-92e8934c7400.sorted_genome_alignments.bam,42,E9F19AD6-67CB-469A-BCE1-92E8934C7400,4ee51f8b-ca57-404d-80b3-ccd66735260b,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,FB1A5736-8CE6-4891-A1AF-F257ACDEDDA0,Alive,Roswell Park,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,49.48,RNA,,,,,Alive
s1024,E54E9EE7-063B-4A1B-B46F-33903CE3BAC5,UNCID_2373805.7374c112-195a-4bb5-b047-cdc99b0841ec.sorted_genome_alignments.bam,37,7374C112-195A-4BB5-B047-CDC99B0841EC,eda639d8-befb-44c8-97c0-4a5d2eeb152f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,692E1D4B-EFDD-4C1A-A7C0-2DF073EBC630,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.82,43.93,RNA,,,,,Alive
s1054,C6F0A177-4766-4F35-91BC-14214DBE84C9,UNCID_2374023.43294ec5-2c5b-4931-8c24-af98a08d5213.sorted_genome_alignments.bam,41,43294EC5-2C5B-4931-8C24-AF98A08D5213,5a36b7af-70c6-4a08-84ac-01ef15739337,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,2FE3777B-9CF4-49D0-9238-85405BEBDD33,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-93,C48.0,C48.0,NO,YES,Stable Disease,30.0,0.17,1.9,25.94,RNA,,,,,Alive
s991,D72CB6AD-2F22-4C52-8D60-914DE1AC421C,UNCID_2373887.b5c88aed-daf9-4746-9b87-44ec9ce1a70a.sorted_genome_alignments.bam,40,B5C88AED-DAF9-4746-9B87-44EC9CE1A70A,3cd6e040-2cdd-401f-8678-d79dafc602f3,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,13FAF460-7349-46A9-9464-D67C9A9CB456,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.96,34.13,RNA,,,,,Alive
s1082,86B3EEF1-031C-47F8-A217-CCE8979D39D9,UNCID_2380922.6d552bed-1386-4a0e-bbb5-6abacd2c2cb1.sorted_genome_alignments.bam,44,6D552BED-1386-4A0E-BBB5-6ABACD2C2CB1,b5b31686-995b-433a-afab-6eee027817ba,755.0,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A564331F-9ECD-4BB6-906B-413597BA17D5,Dead,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Progressive Disease,30.0,0.16,1.88,40.63,RNA,67D28CD6-23AA-44F4-8707-C0709D9BD5FE,Not available,Systemic,,Dead
s1043,CBE614C8-D88A-45CE-BEE4-7215B80D6971,UNCID_2374163.151007c3-6f83-4ea6-9bd7-1cdcad4b61c7.sorted_genome_alignments.bam,47,151007C3-6F83-4EA6-9BD7-1CDCAD4B61C7,1586cc02-8405-4a9b-8a89-ac4c706ce3b8,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1C988959-57E1-461C-8781-7D9F72D40B0C,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.87,35.16,RNA,,,,,Alive
s960,D42704BA-2BF1-41B9-B646-FA5016FB7740,UNCID_2364259.0911ea83-66b8-4255-96a4-cf5b22223cf0.sorted_genome_alignments.bam,70,0911EA83-66B8-4255-96A4-CF5B22223CF0,2efa48c7-c6a5-4d86-86e1-6f338b2b1ad1,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,88D60FC5-07C7-4D30-9330-A134CB30CEFB,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.84,35.83,RNA,,,,,Alive
s1029,6923EF79-19B1-4EED-B2AE-D66F7588C7F7,UNCID_2378078.c688d205-4bc6-4b47-bf68-f77fa0ade2a5.sorted_genome_alignments.bam,63,C688D205-4BC6-4B47-BF68-F77FA0ADE2A5,fdca4077-a00c-42fc-81cb-fac96834e753,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,AMERICAN INDIAN OR ALASKA NATIVE,HG19,Primary Tumor,759A57D3-594D-4E85-A340-C8064048A202,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.92,16.78,RNA,,,,,Alive
s946,3B688681-493D-4902-9DAB-188D4EB1A19D,UNCID_2362334.6f669cee-b2a9-4912-b972-2a1f73db4bd2.sorted_genome_alignments.bam,42,6F669CEE-B2A9-4912-B972-2A1F73DB4BD2,7a35d8c4-569f-477f-b985-8f46079419cf,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,4EA4B9CA-55AF-411C-ADF1-5CF98FA00F3B,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.82,9.82,RNA,,,,,Alive
s943,8CFE275A-DA97-415D-8EAB-7DA2BFA27529,UNCID_2362086.a02050d3-7dd0-4c74-afe4-54835d396984.sorted_genome_alignments.bam,51,A02050D3-7DD0-4C74-AFE4-54835D396984,4d961a73-1086-493a-84e8-44e443a5effb,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,AB5D5919-EA1D-41F8-BE76-967223DAD85E,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.86,14.98,RNA,,,,,Alive
s1022,E8810D9F-E9DE-4F8C-8473-DCB1A00026B5,UNCID_2369824.abcb146e-a12e-4400-8d55-856de7fb8492.sorted_genome_alignments.bam,26,ABCB146E-A12E-4400-8D55-856DE7FB8492,f1c22412-f25e-4859-8821-efc674a9c967,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,Not available,HG19,Primary Tumor,8DCC30BC-3100-4F8D-881E-6E8E8789FEC7,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.9,31.09,RNA,,,,,Alive
s1076,CD24B6BB-AEAB-4652-AB15-FF59A84987B0,UNCID_2381073.3fcb60a3-8ee8-48b8-a07e-218ca6dbb24a.sorted_genome_alignments.bam,59,3FCB60A3-8EE8-48B8-A07E-218CA6DBB24A,b4be9e07-e65c-4ef7-9c52-90141f9964fe,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,16145D56-381B-4DE5-BC83-DBCCA86D8126,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.78,36.96,RNA,,,,,Alive
s995,20ACF5F1-59BC-4B37-ADAF-076AE122C8FE,UNCID_2367168.d2589a77-5a81-4e9b-8ca8-5adebb259b54.sorted_genome_alignments.bam,56,D2589A77-5A81-4E9B-8CA8-5ADEBB259B54,764fe189-5b13-4c2a-a1ec-587d462052c6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,ABA9CD29-03DB-4F00-8AED-90480D332D97,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.18,2.26,28.76,RNA,,,,,Alive
s925,E328DB85-5A07-4ABE-807B-0B3EAE00A900,UNCID_2357413.28eca552-d07d-4c6e-b40d-2dab40660aab.sorted_genome_alignments.bam,63,28ECA552-D07D-4C6E-B40D-2DAB40660AAB,ebef1483-e3fd-497c-b694-8c3a4e96102f,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1AD6DBBC-69A8-46D6-A5F2-97D1F346D309,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C38.0,C38.0,NO,,Complete Remission/Response,30.0,0.18,1.94,32.9,RNA,,,,,Alive
s1042,26444263-8EBF-4E2F-8B0B-6B7367B96D1B,UNCID_2374124.c6b39e1f-7695-4b33-a71e-938734a8993c.sorted_genome_alignments.bam,54,C6B39E1F-7695-4B33-A71E-938734A8993C,0f5a4f7f-e2c1-44b9-8421-37090b43c97e,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,611D7F1B-AE58-46FC-B7CA-8D68498E7F25,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.93,44.98,RNA,,,,,Alive
s1058,EC733ECA-BA8A-4123-821C-E88891CF13F6,UNCID_2373943.3cb892b5-2e68-4f7d-8c0f-f6d0a1577e0c.sorted_genome_alignments.bam,83,3CB892B5-2E68-4F7D-8C0F-F6D0A1577E0C,48a17555-a9e5-4943-bd09-5293bff707e3,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,3E54E8BA-E817-47E7-BB7A-FBBE42558A68,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,19.65,RNA,,,,,Alive
s1063,C73BE2F0-BB0A-4EE7-B045-CB57B66D4299,UNCID_2374260.0d31feba-eda3-482c-bcbf-28f28b6cd9b2.sorted_genome_alignments.bam,35,0D31FEBA-EDA3-482C-BCBF-28F28B6CD9B2,6f8df65f-326e-441e-91ac-61e5b32ac16f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,51457EE0-2E47-4C26-A905-5CF996130F65,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,YES,Complete Remission/Response,30.0,0.18,1.92,42.88,RNA,,,,,Alive
s961,9D11E76A-7E34-4470-855E-CA65275FC6EC,UNCID_2363587.e88c6b20-6ca5-4758-a46f-eb2daa1ffac7.sorted_genome_alignments.bam,31,E88C6B20-6CA5-4758-A46F-EB2DAA1FFAC7,d189a52d-b65b-47f8-9f5d-35451829e78b,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,660CE615-9E28-4AC0-BE10-F408031F9899,Alive,Cleveland Clinic Foundation,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.84,27.9,RNA,,,,,Alive
s1057,2EF44862-333F-40D0-8DD4-C8B8A81B4036,UNCID_2378047.342e3c12-c4c5-4fc9-9a6c-babc11ac944e.sorted_genome_alignments.bam,28,342E3C12-C4C5-4FC9-9A6C-BABC11AC944E,6acc035f-e85e-4ede-b630-c225996cea2d,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A3BA67CF-30C1-4E3D-9FB4-BE4EA4D214FE,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.94,28.98,RNA,,,,,Alive
s956,AF11028C-0401-4151-AB3D-A4719E276ADE,UNCID_2363802.c9bd38a7-823d-4019-8016-1e5bd8cd8ee1.sorted_genome_alignments.bam,35,C9BD38A7-823D-4019-8016-1E5BD8CD8EE1,f8d78495-c000-461f-a311-3467fb1178aa,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1961FD02-1596-4F4C-B480-F48DAEA382BA,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,44.18,RNA,,,,,Alive
s1088,D7EFC40B-5767-4C91-A350-8DF58C287DB8,UNCID_2384051.02fffe37-3890-4985-abcc-dc450d300659.sorted_genome_alignments.bam,63,02FFFE37-3890-4985-ABCC-DC450D300659,0fd41168-9c85-4c11-bc2c-3a100b7a16c6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,B963646D-9112-4BC3-A9BE-48C9BD335B23,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,55.53,RNA,,,,,Alive
s949,77FB5AFF-C493-44EE-8B54-91830E3DC645,UNCID_2361985.5bcb5dd5-84a3-48fb-9942-e2f888cbd672.sorted_genome_alignments.bam,43,5BCB5DD5-84A3-48FB-9942-E2F888CBD672,42604f3f-c416-428a-9859-b3734b2a9576,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,AFA2C4F9-1D6B-42A8-9080-775AAF2875C1,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.92,35.18,RNA,,,,,Alive
s1055,DAEC3DAB-51A6-4137-97AB-23A0C842EF20,UNCID_2374206.30bf9d46-b868-43c0-a605-e6808c036d77.sorted_genome_alignments.bam,39,30BF9D46-B868-43C0-A605-E6808C036D77,ea590361-7868-40d7-aa91-1dbd2ea6ad57,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,0E840688-D0B9-4FF5-BF7E-8119A54522E2,Alive,International Genomics Consortium,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Not available,30.0,0.17,1.85,48.75,RNA,,,,,Alive
s987,BF9C17DC-7FE8-41A4-83FF-F615DE518D3A,UNCID_2369920.512bb8af-2748-4186-ac38-f91dc5c683ab.sorted_genome_alignments.bam,75,512BB8AF-2748-4186-AC38-F91DC5C683AB,c7522bed-b672-4f54-bbb7-31698f73f14d,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C484645F-AD5B-440D-B436-E0585A5D6099,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.18,1.81,22.24,RNA,,,,,Alive
s981,34854213-CC4F-4786-AE2D-9485F84A2A55,UNCID_2367156.8f143ea3-314d-4d89-ad70-6209ff9852d4.sorted_genome_alignments.bam,42,8F143EA3-314D-4D89-AD70-6209FF9852D4,59f305d2-dca8-4ec7-8708-27b4b105fc72,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,7E8299EE-2FE1-49D5-B2C4-5F0F2F79272F,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,YES,Progressive Disease,30.0,0.16,1.92,40.01,RNA,,,,,Alive
s913,C81D0F8F-8016-41EE-B70B-9DB42B0FF3C0,UNCID_2357314.091fa855-e030-43c9-9abe-62e9e17e3e11.sorted_genome_alignments.bam,56,091FA855-E030-43C9-9ABE-62E9E17E3E11,38d7c7a6-c907-4f9b-ad34-47776e5babdd,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E5A35A7E-57B9-4D5A-8EF0-0B6D0CEE3633,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.85,19.01,RNA,,,,,Alive
s918,B1533438-5EF7-4659-AB67-9A388232D555,UNCID_2357764.21363134-c998-4af5-8052-59fa30f18176.sorted_genome_alignments.bam,53,21363134-C998-4AF5-8052-59FA30F18176,885b069f-858e-4ecc-a2a5-e62d949c73aa,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A0761BE2-F9A1-4222-BE66-74D9B0785010,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.83,17.66,RNA,,,,,Alive
s951,E72D5934-30BC-485A-BAD3-F309832FCF4D,UNCID_2364211.ab73be97-98a8-424d-babf-c6802c10dc1e.sorted_genome_alignments.bam,33,AB73BE97-98A8-424D-BABF-C6802C10DC1E,b19c825e-33b2-4ff5-86bf-ad352e53a710,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,AF0CF2EA-F1D7-4EA3-93B8-1E824B9E56C6,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C76.1,C76.1,NO,NO,Complete Remission/Response,20.0,0.16,1.9,32.23,RNA,,,,,Alive
s963,4888AE35-1785-4FAD-B6F0-E75952FE7DFB,UNCID_2362578.e37650fb-30e7-4fc5-bf02-25d5dbfccc29.sorted_genome_alignments.bam,27,E37650FB-30E7-4FC5-BF02-25D5DBFCCC29,13400e89-950f-437a-9c90-636def39318c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,79CF0D68-C5AF-4119-B0E7-8D8E17F2E0B4,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C49.6,C49.6,NO,NO,Complete Remission/Response,10.0,0.16,1.94,7.49,RNA,,,,,Alive
s1026,26C1B9B3-3D39-44F7-8561-0A15DC60A000,UNCID_2378133.09eb0599-7435-4c1f-b96b-a02a490fb246.sorted_genome_alignments.bam,41,09EB0599-7435-4C1F-B96B-A02A490FB246,f83ee2a0-001d-4575-9c43-6ff5a0c3f5c7,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,037C4A93-58D5-46EB-902A-7DF2C3852FE6,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.73,36.07,RNA,,,,,Alive
s1007,72ABE808-D870-4D3C-A913-3A98C6201C03,UNCID_2367023.92d92d33-6f95-4b8f-ad23-bb87d43773de.sorted_genome_alignments.bam,41,92D92D33-6F95-4B8F-AD23-BB87D43773DE,1a1cf490-8bd4-4a99-bf3a-34f06435de86,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,5D5ABC7E-F80B-48CE-9591-62C198C40AAB,Alive,St. Joseph's Hospital (AZ),University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-93,C76.0,C76.0,NO,NO,Complete Remission/Response,30.0,0.16,1.98,26.17,RNA,,,,,Alive
s1034,6DD6827F-C337-4027-B0CF-494D0B41F642,UNCID_2378246.801f506a-c31c-47a9-9cd6-cfe7da0222c8.sorted_genome_alignments.bam,40,801F506A-C31C-47A9-9CD6-CFE7DA0222C8,0024ab57-4036-4b0f-b7a1-040f97787022,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,16547968-28EC-41FF-B5AD-B3C9F89F467A,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.85,41.13,RNA,,,,,Alive
s1015,01C74463-52C4-4936-AD80-7602AFFD8E27,UNCID_2367473.269e47df-94de-4d27-86be-3a404cdaaf08.sorted_genome_alignments.bam,50,269E47DF-94DE-4D27-86BE-3A404CDAAF08,215f8eb1-bb6d-4f80-9681-3e9f2064a4d9,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,36192EF3-5097-4F48-87FA-2BF32DB81F17,Alive,Cleveland Clinic Foundation,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.85,42.93,RNA,,,,,Alive
s979,DCF4B21C-2EB1-4178-8477-3A17DD78F3BD,UNCID_2366861.cf37c1f7-bda9-4cd2-a3e9-a7c11f7707ca.sorted_genome_alignments.bam,47,CF37C1F7-BDA9-4CD2-A3E9-A7C11F7707CA,613c3096-7d23-4404-b236-b053485541f3,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,598D89B2-B169-4DFB-8B31-C7A0C4520272,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.9,14.63,RNA,,,,,Alive
s1059,2AC4A132-1384-4327-B27E-ADB1F2946B17,UNCID_2375240.7fa1bbfe-f0e7-40d9-97fb-992b97729f96.sorted_genome_alignments.bam,76,7FA1BBFE-F0E7-40D9-97FB-992B97729F96,1f9df922-91be-41b6-8dbe-ac2d27c8b836,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C62BA195-2F51-4269-A4D5-2EE2F44E3818,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.83,29.25,RNA,,,,,Alive
s1086,DFCB58D0-5C26-48EB-9BF3-DAA792572DAD,UNCID_2380903.081322b7-2088-4950-bfc6-8ce215869974.sorted_genome_alignments.bam,57,081322B7-2088-4950-BFC6-8CE215869974,47016ea9-afd6-4ad4-97f5-4b40b8a6f075,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,4F7564F9-DF0C-4D87-A0A1-F1F79537F522,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.75,41.66,RNA,,,,,Alive
s1053,07041878-AEA3-457E-B8DF-C7D540B682FB,UNCID_2374374.639eeaea-0da3-4bf5-9ec7-f5cd356142ed.sorted_genome_alignments.bam,37,639EEAEA-0DA3-4BF5-9EC7-F5CD356142ED,91e37435-16a1-4077-b342-83826480fdc9,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,591DB6B9-CE9A-4AB5-8860-792DB1D11520,Alive,University of Pennsylvania,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,35.35,RNA,,,,,Alive
s969,A9208D42-B779-4B1A-A23F-BE21B125632C,UNCID_2366728.734756ba-8004-4b24-837a-75f326d1df08.sorted_genome_alignments.bam,43,734756BA-8004-4B24-837A-75F326D1DF08,2bfe97f0-6590-4be0-b82f-00c20998fb4f,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,0AE37426-A674-440D-9C64-58CF91119641,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.87,27.99,RNA,,,,,Alive
s1065,8C70F4A1-DC11-452C-A482-8B7D05B65242,UNCID_2377968.b0d0bc0c-201d-42c0-988b-11f5aab60ede.sorted_genome_alignments.bam,49,B0D0BC0C-201D-42C0-988B-11F5AAB60EDE,20e793c4-4e13-47f5-8f41-33cb1bac4c6b,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,62BFF12C-FA1A-4CFB-BF28-4C34D1FBD5F6,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.89,39.96,RNA,,,,,Alive
s973,EDCF4682-C855-48AB-BBBA-DD8C38700BC4,UNCID_2362037.ffe5c342-c91a-46da-8cf3-0a86b9ca9608.sorted_genome_alignments.bam,30,FFE5C342-C91A-46DA-8CF3-0A86B9CA9608,5ce3a0b8-a05c-4a71-86e0-ff9a34517cea,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,2D490905-7DDA-4676-8BAF-9DC90E8B7C21,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.9,25.48,RNA,,,,,Alive
s1023,4D854056-FE0A-46BB-8A9F-6BE310A1579B,UNCID_2369585.6e8968b9-e233-4938-8e66-79b1181e23b0.sorted_genome_alignments.bam,46,6E8968B9-E233-4938-8E66-79B1181E23B0,8bbfad51-08e8-443e-8a08-e714d264f7b8,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,12FD8AD4-507E-444E-8560-EC79610AB8F0,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.79,32.4,RNA,,,,,Alive
s1005,A3B5970A-A546-4D38-8347-1A22E35561EF,UNCID_2369726.62120496-0ec0-445b-8cf7-5335dc6eb2ae.sorted_genome_alignments.bam,43,62120496-0EC0-445B-8CF7-5335DC6EB2AE,5f7855e5-6170-4047-a441-ed6c9a4b3f13,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,348FEEE4-393A-4D40-820D-F37BB65382CA,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,34.83,RNA,,,,,Alive
s1009,5E3E36AB-F6D9-411E-BF71-A7EEAA47F2D5,UNCID_2369947.91ec8922-93e2-4e55-ae26-db5e4a71b953.sorted_genome_alignments.bam,51,91EC8922-93E2-4E55-AE26-DB5E4A71B953,939734bc-257b-42f0-9928-b8c4f283fb18,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4077AE07-C34E-469C-9D39-5F8C5F168F6D,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.92,31.09,RNA,,,,,Alive
s1030,3DFC5463-D0D4-43FE-931D-37EB7984C8CD,UNCID_2374114.ceffbb74-affa-4aca-a90b-e5f9d55ad39f.sorted_genome_alignments.bam,19,CEFFBB74-AFFA-4ACA-A90B-E5F9D55AD39F,5047e5dc-6b4c-4708-bf25-984b27a87882,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,51508C41-F3CF-4CB3-9DB2-42531BF7A867,Alive,University of Pennsylvania,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,45.53,RNA,,,,,Alive
s977,9D8F6191-5C29-47C3-BF41-2DAF9BE823C6,UNCID_2373755.90f060d8-632f-466e-9175-e4e1748d684f.sorted_genome_alignments.bam,64,90F060D8-632F-466E-9175-E4E1748D684F,eb7ef915-3b28-4ffb-b996-d7c89a6210ac,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,45E8AD06-C789-4551-A964-4083FAC3167D,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.16,1.94,28.65,RNA,,,,,Alive
s1049,021ABAE5-87EB-4039-A493-4768E25637C8,UNCID_2380667.83478c86-d662-4b9c-b5fa-c09cf1c6d00d.sorted_genome_alignments.bam,64,83478C86-D662-4B9C-B5FA-C09CF1C6D00D,fc5d4277-68a3-41c7-b0c6-d6922984ae9f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CC22FBF2-CBEC-4FC9-BE75-CA74FCD6B552,Alive,University Health Network,University of North Carolina,Canada,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.81,35.2,RNA,,,,,Alive
s993,5058D1AE-5A6C-4083-8F9F-6C9D98C9BC4D,UNCID_2373644.6eed26fc-d4c7-4fb9-99c0-54ea55e09091.sorted_genome_alignments.bam,73,6EED26FC-D4C7-4FB9-99C0-54EA55E09091,cec25604-3e90-4d2b-83aa-cda3f4b442b9,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,21221C70-EB36-4C3F-89CF-2C7A1E5999FF,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.76,39.91,RNA,,,,,Alive
s915,45CD3665-5154-4E8A-9924-3C5D2AE48B79,UNCID_2357831.822e5a1e-8118-4940-8bd4-bc3f8d678c09.sorted_genome_alignments.bam,55,822E5A1E-8118-4940-8BD4-BC3F8D678C09,2ad0c1dd-d7d3-4349-8c3d-1faa871fc2d2,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,78C4DC7F-BB0D-4881-9E35-968DB36908F0,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Not available,30.0,0.17,1.87,36.68,RNA,,,,,Alive
s1080,D5323024-6DA2-472B-A618-CC60F9705D59,UNCID_2384067.ebafc56b-e0e8-45b0-a36c-cc9f4de2e14e.sorted_genome_alignments.bam,49,EBAFC56B-E0E8-45B0-A36C-CC9F4DE2E14E,054b81ac-963f-4f49-950c-ae03144af348,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,2B46B4CD-BC1A-4540-BFAD-F034C3E05817,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,YES,Complete Remission/Response,30.0,0.18,1.81,33.54,RNA,,,,,Alive
s920,8113CACE-8320-40ED-94DC-119143716959,UNCID_2358228.9959f266-1024-4dfc-b1d8-3c3a3cf2125d.sorted_genome_alignments.bam,31,9959F266-1024-4DFC-B1D8-3C3A3CF2125D,e858545a-cdd4-4fca-b04d-485b274208bd,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,ECD9AE42-C10D-4AC2-AC36-3D60191910EF,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.87,11.09,RNA,,,,,Alive
s964,DEA837B4-3439-4A4C-82DB-9A5B23538AA5,UNCID_2362191.c6b67553-7a87-468e-90fd-cb6df1e5db5b.sorted_genome_alignments.bam,38,C6B67553-7A87-468E-90FD-CB6DF1E5DB5B,39c2e892-10b3-4369-922b-9491f5112af0,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,278607EE-4EE5-409F-BF78-5EB74DAD6BEE,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.84,29.62,RNA,,,,,Alive
s959,15DC5074-C4D1-4845-9606-806397F782AD,UNCID_2362128.776d3a26-fa83-4b65-ad9b-f7d0fd3d5585.sorted_genome_alignments.bam,53,776D3A26-FA83-4B65-AD9B-F7D0FD3D5585,800e4387-3012-4673-87b3-a88b14234a4e,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,7C8C1AD3-D2A6-445C-8B73-B6AD917BD66D,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-80,C49.3,C49.3,NO,NO,Complete Remission/Response,30.0,0.15,1.85,24.98,RNA,,,,,Alive
s970,03894CDF-312D-450C-B817-2940B3040884,UNCID_2362357.db8d4662-feee-44d6-9825-5ad9424640a2.sorted_genome_alignments.bam,43,DB8D4662-FEEE-44D6-9825-5AD9424640A2,8e3a6536-befb-42fe-be61-6d2428ed7df6,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,462C83EA-58F9-4F01-89CF-A607C4E834DF,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.87,25.27,RNA,,,,,Alive
s988,256CD3FF-75C0-493F-BAC8-6977EF554865,UNCID_2366862.274eebbb-f481-4c6b-bae3-da27efdef3d5.sorted_genome_alignments.bam,47,274EEBBB-F481-4C6B-BAE3-DA27EFDEF3D5,c0b5e10f-e3cc-443d-aca4-ea2928463001,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,09D7FAB5-A646-463D-B12C-5E534D19423B,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,2.08,20.57,RNA,,,,,Alive
s1036,C39A2013-2D05-440B-ADCE-068252F2DFF9,UNCID_2377954.01f0386d-7263-42c4-8b4f-0ce542414c6d.sorted_genome_alignments.bam,35,01F0386D-7263-42C4-8B4F-0CE542414C6D,66af140d-deab-440f-bb58-b8c3da2c3ca5,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,995D28CC-BA2A-4791-A3B7-3DD379DBA04C,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-80,C74.9,C74.9,NO,NO,Partial Remission/Response,20.0,0.18,1.92,32.38,RNA,7304EBA2-3EB2-4AEE-8638-2205DD3DE39D,Not available,Systemic,,Alive
s922,9539F86B-D2DC-403A-BA3B-B5DFEDDD855C,UNCID_2357355.b53cf9af-aa70-416e-b430-1271660c6841.sorted_genome_alignments.bam,62,B53CF9AF-AA70-416E-B430-1271660C6841,f36583af-cc6b-4985-8d11-307970d11008,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,0DA6422B-90E0-4D14-99DD-55DB30DE5D61,Alive,Roswell Park,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,40.55,RNA,,,,,Alive
s1071,366BDF96-E166-4F4B-A4E3-5071BC58364D,UNCID_2375628.4d01a3d8-d9b7-45e7-82d6-420c5d786de2.sorted_genome_alignments.bam,55,4D01A3D8-D9B7-45E7-82D6-420C5D786DE2,065f7b7a-05ee-4728-bcfc-6095357512a6,95.0,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,07938EED-25A4-4F64-B80C-63E5A9DCA148,Dead,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-80,C72.9,C72.9,NO,NO,Progressive Disease,30.0,0.18,1.88,18.93,RNA,,,,,Dead
s945,F875F7CC-A944-49FB-81E4-85F2E59FEFCF,UNCID_2364149.d9120f00-7f10-49d5-ae84-6177e9424c7c.sorted_genome_alignments.bam,36,D9120F00-7F10-49D5-AE84-6177E9424C7C,13b41b15-a785-4ab7-b864-ffff6d35dd45,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,D43F727A-96D6-40B8-86AE-7A3E0AA46853,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.98,22.18,RNA,,,,,Alive
s1093,63EB4037-79D9-46D9-AEA7-488393335C33,UNCID_2380876.89ba1e47-fba2-4222-aaeb-bb2365807fbd.sorted_genome_alignments.bam,23,89BA1E47-FBA2-4222-AAEB-BB2365807FBD,826ec350-7096-40b8-93f7-6c9205acf7f6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,406D819E-FCAA-4318-8DA7-FE427E80ABC4,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,YES,Progressive Disease,30.0,0.16,1.78,28.67,RNA,,,,,Alive
s1021,DC8D975B-993F-49B6-A48E-A1C211697D15,UNCID_2373838.b85005d9-b5ed-4b0c-8a8d-adaeac34b08e.sorted_genome_alignments.bam,80,B85005D9-B5ED-4B0C-8A8D-ADAEAC34B08E,d695e03c-4cf2-4abc-b0f3-ba3067bd03ad,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CA11B271-5DC3-47FA-BE2B-DB767038B6A3,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.94,28.13,RNA,,,,,Alive
s1090,D932DBDA-1DED-4D03-A76F-6534F5FACFEF,UNCID_2382136.068b2053-5df0-411c-9384-f3bd52c76065.sorted_genome_alignments.bam,82,068B2053-5DF0-411C-9384-F3BD52C76065,df992f6c-27a8-440b-a0ec-bbc40b931d36,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,D8CEA3B1-17B8-45E5-94C5-3577FBAB95E4,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.89,25.55,RNA,,,,,Alive
s1073,B102BE25-EC28-477C-A855-956AB2F01E94,UNCID_2380697.749030db-8f34-4348-a3b2-143600d7aad2.sorted_genome_alignments.bam,57,749030DB-8F34-4348-A3B2-143600D7AAD2,cc9f570c-0bde-4485-afd7-eaeed41254fc,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,5BC65691-B720-437F-8008-0DF35F15F657,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.17,1.92,18.48,RNA,,,,,Alive
s1098,88AB28EF-4A05-4FF4-A8A3-0B4E0BC487D3,UNCID_2455421.8f7f8fcd-829f-44fc-83d0-20fe5ddb8642.sorted_genome_alignments.bam,75,8F7F8FCD-829F-44FC-83D0-20FE5DDB8642,cd24b9f2-f550-4b83-aa7a-d16c9d130cb2,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1C3F614C-D63C-4224-92F8-9D1E9C2B38A2,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Jan-93,C49.5,C49.5,NO,NO,Complete Remission/Response,30.0,0.17,1.88,22.18,RNA,,,,,Alive
s999,9520AA39-A72B-484A-8DA4-2DDF06644E64,UNCID_2369395.ddcac11d-6dc7-4183-b685-5b4cfb573222.sorted_genome_alignments.bam,53,DDCAC11D-6DC7-4183-B685-5B4CFB573222,634c7876-21c1-43ea-aa2e-83e9f627409f,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,501332A1-A540-4362-BAB8-8118206085E2,Alive,International Genomics Consortium,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Not available,30.0,0.17,1.85,35.26,RNA,,,,,Alive
s974,55FB3F75-5799-4668-B7A4-51EB440A6B1E,UNCID_2362638.f8c789c9-629e-4a36-9cbf-2e52ecabe74c.sorted_genome_alignments.bam,48,F8C789C9-629E-4A36-9CBF-2E52ECABE74C,6ad83e51-2703-474c-83db-ee86bf13ac36,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,17892371-C314-4149-BEE3-3E6E52FFB41A,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.1,C74.1,NO,NO,Complete Remission/Response,30.0,0.17,1.87,28.18,RNA,,,,,Alive
s923,2788CA49-343F-41D9-B025-EE28E396464A,UNCID_2357700.e8900d00-89cd-43b6-8806-1693c33c8499.sorted_genome_alignments.bam,23,E8900D00-89CD-43B6-8806-1693C33C8499,a3b165e0-bec1-4dbc-b2d8-08fa21874cfa,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C7F20AE5-305D-4A48-B9EF-E67E7EE7C6E2,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,YES,Complete Remission/Response,30.0,0.17,1.92,26.54,RNA,,,,,Alive
s1069,7815F3C0-596F-4337-8BA7-B85BFF74CB7E,UNCID_2378322.f15ef4cf-2f81-4c1d-b89c-2f88e33c324d.sorted_genome_alignments.bam,45,F15EF4CF-2F81-4C1D-B89C-2F88E33C324D,4142a680-00d2-4f49-91b8-1e5c25f1713e,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,4E12A445-BAF1-4F7E-B389-5F6506133F44,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.18,1.89,25.2,RNA,,,,,Alive
s1038,5CA2F3C5-41DE-4536-97D8-8DA0A696F7C3,UNCID_2375310.76ed9300-2e50-4791-973c-6ee8bec19f6f.sorted_genome_alignments.bam,25,76ED9300-2E50-4791-973C-6EE8BEC19F6F,93188b85-4361-4908-9db5-889c94c02c73,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CF553C75-BEF2-4FF6-84C2-A53F05FE362F,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.88,25.83,RNA,,,,,Alive
s929,9DE890ED-4932-45E2-8B67-A78D3C808ED5,UNCID_2363618.483dc49d-24ad-49e2-b6eb-cf690eb2509c.sorted_genome_alignments.bam,51,483DC49D-24AD-49E2-B6EB-CF690EB2509C,813375ef-b895-4c7c-9e98-55a00f98da95,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,F89FA4CC-A6B6-4D58-99F3-2F3EA5F79EBD,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.88,46.39,RNA,,,,,Alive
s1046,0576CA24-120B-465E-B06F-9F9F85F7C663,UNCID_2377933.2ea07252-37a1-4c62-924c-6674242fe238.sorted_genome_alignments.bam,68,2EA07252-37A1-4C62-924C-6674242FE238,7395b02f-c0db-449d-a51a-64e80b619ad7,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,6F01B62E-B562-4FFE-BE11-BD6F178C99F9,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.78,30.38,RNA,,,,,Alive
s1066,8916C677-DCDE-4F76-8F62-93E36ABCE911,UNCID_2378173.83afb7e3-b801-464e-a6dc-5128f336a113.sorted_genome_alignments.bam,45,83AFB7E3-B801-464E-A6DC-5128F336A113,ffbef57b-3627-4d6d-8857-a90e83911480,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,Not available,HG19,Primary Tumor,52F21FBF-A34F-46EF-A0C7-F711B181A18C,Alive,University of Pennsylvania,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.18,1.84,31.19,RNA,,,,,Alive
s1008,7851030C-BE2F-47E9-9DC8-2A81A7C24D46,UNCID_2367069.57cb9b37-a93a-4b21-bac5-e588e56612b4.sorted_genome_alignments.bam,69,57CB9B37-A93A-4B21-BAC5-E588E56612B4,a7809d38-985d-4d0e-9bec-3fdb6536be45,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,56FE846C-F5AD-4F7E-B25C-9D7A3AF067E6,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,YES,Complete Remission/Response,30.0,0.16,1.8,34.29,RNA,,,,,Alive
s1056,3B739124-E02F-4CF5-9A95-BAA7003C48D8,UNCID_2374027.f788beee-beb2-442a-9a18-e5674e889707.sorted_genome_alignments.bam,69,F788BEEE-BEB2-442A-9A18-E5674E889707,20c31348-e871-4abb-8ec6-5124f8d0170e,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,418BDBA2-4547-4883-B23E-067D198247F3,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.17,1.92,24.18,RNA,,,,,Alive
s1012,E2949A80-BF6F-4CAD-98C2-7DD061920F2B,UNCID_2369799.0d996919-44ed-43cc-a2ae-99c684ac2707.sorted_genome_alignments.bam,63,0D996919-44ED-43CC-A2AE-99C684AC2707,08dd606a-1982-4cb9-bcd6-09d4bc158f6d,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E3BF8F6E-EF30-45C0-B916-146423098117,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C48.0,C48.0,NO,YES,Progressive Disease,30.0,0.17,1.85,12.1,RNA,7695CDAA-FB7F-42C4-9F21-95E0507FA094,Distant site,External,,Alive
s928,1188FB49-139B-4515-AE1E-37F6686E4518,UNCID_2363586.8a2e5312-9379-4355-ab4a-31de5065d3dc.sorted_genome_alignments.bam,62,8A2E5312-9379-4355-AB4A-31DE5065D3DC,8b8dadd8-781a-42bd-a59d-4ff5c301b1df,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,5BC1936E-49D1-4843-99BF-C032DF997F8E,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,37.3,RNA,,,,,Alive
s952,819EE7FF-6239-4CC6-85BE-A9F8B01D13C0,UNCID_2362195.cf58f205-e3e2-4eec-8df2-22adf77d6ec1.sorted_genome_alignments.bam,31,CF58F205-E3E2-4EEC-8DF2-22ADF77D6EC1,3f7bcf11-6fe3-43df-baae-e87821526ccd,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,E0B3E8C0-2AA8-4CE0-8342-0C497B18B258,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.83,43.5,RNA,,,,,Alive
s917,7E7326CD-62C5-40FE-83E0-53BBCAC83C84,UNCID_2357603.2dc9f559-fbfd-4290-82d2-e65bc3d8c0e4.sorted_genome_alignments.bam,78,2DC9F559-FBFD-4290-82D2-E65BC3D8C0E4,cae03180-01e5-41aa-88c2-da9c233778d8,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,871F2796-EC9B-4F38-9113-3BF36B72A1A0,Alive,Translational Genomics Research Institute,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,27.94,RNA,,,,,Alive
s1091,7275980F-98C0-4B5A-9AAD-525E5829866E,UNCID_2384133.02ad7be5-f194-4d34-a61d-40138d07477f.sorted_genome_alignments.bam,24,02AD7BE5-F194-4D34-A61D-40138D07477F,3354dc26-9ad9-47b6-8d8a-c3bc28eaac15,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,85707D9F-3C2D-4465-B618-82F23B3E6101,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.8,33.23,RNA,,,,,Alive
s1017,C21BABF6-347A-43E9-A930-E559CCF6435F,UNCID_2367166.355fc3cd-c43b-41cd-b608-3e88100693fd.sorted_genome_alignments.bam,72,355FC3CD-C43B-41CD-B608-3E88100693FD,d1eea093-f349-435f-b8d4-1b40b35503d7,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1D79930A-E91C-4BA8-B63D-D478077D76C5,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Complete Remission/Response,30.0,0.18,1.93,34.4,RNA,,,,,Alive
s976,A6C2B101-CDD2-4C80-BD20-510E7419E643,UNCID_2369470.c64368f9-ec98-4417-bc41-c19ae5b043a5.sorted_genome_alignments.bam,64,C64368F9-EC98-4417-BC41-C19AE5B043A5,3a0e73ce-ba5b-4f6c-ba56-7dcc28d7c1e1,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,E13F98D2-3B41-4171-B9BF-5A638EFC4402,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,24.61,RNA,,,,,Alive
s982,9A0E1B80-1908-4680-BC2D-ABD244528749,UNCID_2373684.2a8232ef-ce9b-47f7-9b78-da42ac45355f.sorted_genome_alignments.bam,44,2A8232EF-CE9B-47F7-9B78-DA42AC45355F,831da39b-2b1c-4b9d-b101-e71ddf2e83a6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CBE96DB6-9E58-4054-A7FF-B9BCD50A000A,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.92,31.75,RNA,,,,,Alive
s947,E24FEB8F-BBB6-4799-833E-17AE414CCF5B,UNCID_2363815.93ae706d-cb90-4893-aa69-b46561e5ea6e.sorted_genome_alignments.bam,40,93AE706D-CB90-4893-AA69-B46561E5EA6E,9bfabde9-cad4-4b34-bfff-397b1c5636b0,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,6CE29B55-C2AF-4AF2-BFB8-4B73050F39C6,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.1,C74.1,NO,NO,Complete Remission/Response,30.0,0.18,1.98,38.52,RNA,,,,,Alive
s948,EEF02FCA-E16F-4179-919A-BE9812205555,UNCID_2361956.1a166c96-b6cc-4398-a1ca-d23c255fd783.sorted_genome_alignments.bam,54,1A166C96-B6CC-4398-A1CA-D23C255FD783,6e419c1d-1aea-438e-98a4-8bf048bb9a1c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,3C1E89E9-3C83-459C-9053-2742EFC42FF0,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.8,30.85,RNA,,,,,Alive
s989,722D1AF3-04F5-4B5A-9E30-1D77403B9D7E,UNCID_2366887.5b56898c-ea92-4ef1-a877-b68b0c40d1ba.sorted_genome_alignments.bam,19,5B56898C-EA92-4EF1-A877-B68B0C40D1BA,fc0e7281-6e0e-4057-b064-7d8b3060d134,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A42BF8A2-C4BD-4BF6-80D2-E60FB86BFF7A,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,26.5,RNA,,,,,Alive
s1037,85748697-8C17-412B-8480-D2C25C09E68E,UNCID_2374484.ad7199e5-0e3c-44dc-9166-7d3b23fe43e9.sorted_genome_alignments.bam,64,AD7199E5-0E3C-44DC-9166-7D3B23FE43E9,06b763de-68f6-42fd-9aac-4cc4f96e901e,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,C4E34043-169A-4ED2-85E3-135DEA23CB8F,Alive,University of Pennsylvania,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.79,19.28,RNA,,,,,Alive
s1051,93ED27D3-0EF0-439E-8E03-9F53D545B059,UNCID_2374317.b4028e6e-0010-42a3-b84b-e4c5594c86df.sorted_genome_alignments.bam,23,B4028E6E-0010-42A3-B84B-E4C5594C86DF,272589d0-8994-44e4-b434-b03cd036fb32,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,C52941C5-E29B-4921-B3A8-4CAEA48FA7DF,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.88,31.09,RNA,,,,,Alive
s1001,63CDD075-A286-4A9E-A064-9122BF9DD024,UNCID_2369261.48360943-522a-4dbe-a99c-5a1ac8fc4e47.sorted_genome_alignments.bam,55,48360943-522A-4DBE-A99C-5A1AC8FC4E47,7f4af1ae-da2d-4ecc-8f7a-6255e5c77e91,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,29ED64D5-B9C8-4440-8F5D-F525E7160C5A,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.84,21.26,RNA,,,,,Alive
s1027,4843FEC8-AD0F-4FB6-B047-8E30CFED2238,UNCID_2380700.1d3edb73-2445-43e4-b33e-be68b26c63f3.sorted_genome_alignments.bam,25,1D3EDB73-2445-43E4-B33E-BE68B26C63F3,93fffb9e-e065-40dc-8eaa-62c9f35560c4,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,30F60959-F4B7-4EBC-9973-9448DCA71B8A,Alive,BLN UT Southwestern Medical Center at Dallas,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,YES,Complete Remission/Response,30.0,0.18,1.91,15.73,RNA,,,,,Alive
s1016,8FA4B9E9-3A62-4AD0-BAEA-71C9F6A7B6E8,UNCID_2366921.b3133dcd-d39f-441d-b553-0fe4553fc2ed.sorted_genome_alignments.bam,56,B3133DCD-D39F-441D-B553-0FE4553FC2ED,f76d85c2-e1f8-4759-a1fa-f8ed273ddb49,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,07E34169-5DA7-441D-840C-C3FF13A9ED78,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,30.93,RNA,,,,,Alive
s971,37D097FF-47BD-4006-BEF6-FE2D5ACD1EA6,UNCID_2362192.9a738f7b-2a84-47af-bba4-b79a945872e2.sorted_genome_alignments.bam,67,9A738F7B-2A84-47AF-BBA4-B79A945872E2,ec54924b-2463-4364-a8fc-6d5a7df0b444,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,8AE2A6F3-5F4F-41FF-BCC8-9FBCD906FB57,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,YES,Progressive Disease,20.0,0.16,1.86,26.86,RNA,,,,,Alive
s990,5A54CF03-B29A-496C-B848-F4A7B59EA36F,UNCID_2369752.79ad5242-1b2c-4838-b5b6-93fd88ed98d8.sorted_genome_alignments.bam,57,79AD5242-1B2C-4838-B5B6-93FD88ED98D8,bcc5dd5c-b979-4b45-aae5-b2c9871766e6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CCD876E3-C9AD-418D-A05B-4D6EF77D3D1A,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.0,C74.0,NO,NO,Complete Remission/Response,30.0,0.17,1.83,23.95,RNA,,,,,Alive
s1019,B71DAFD9-0330-4EA9-AE84-9CAB846A394C,UNCID_2367216.9ee6277c-e6d1-494e-92b9-1df4b81ba155.sorted_genome_alignments.bam,66,9EE6277C-E6D1-494E-92B9-1DF4B81BA155,36905596-8480-4bcb-841b-520f48a936f9,88.0,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,B658F094-EE58-4FE8-BCF3-956777864450,Dead,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Not available,30.0,0.16,1.94,47.95,RNA,,,,,Dead
s992,83D6E6A6-2BA6-4B6F-AFF5-05376DAC3B1A,UNCID_2369361.1971661a-5b77-4c90-8c1a-c81e9abebec5.sorted_genome_alignments.bam,40,1971661A-5B77-4C90-8C1A-C81E9ABEBEC5,7d073a9e-2a26-4cc7-8b3c-120c551b9a0c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,73ADD7ED-46B2-4791-A012-54706B0A0C14,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.87,42.86,RNA,,,,,Alive
s972,CE625424-7A6C-4C4C-9865-DFA792314E05,UNCID_2363756.79cbef95-e0ce-40bd-8c93-5d2383ad4cbe.sorted_genome_alignments.bam,46,79CBEF95-E0CE-40BD-8C93-5D2383AD4CBE,1c1b02c5-0c95-4638-a5cd-e569e8ca41b6,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,FBB15CDF-EFEA-4795-A4F1-E865635923CB,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,44.32,RNA,,,,,Alive
s1041,B8E1B4B1-50DB-4F12-B43D-4FDE98B7C52C,UNCID_2373981.bf24582f-1c4b-419a-8ee2-58d8531dde5f.sorted_genome_alignments.bam,25,BF24582F-1C4B-419A-8EE2-58D8531DDE5F,686ff2ea-e95b-4a08-a3d8-fdfa67fa9b92,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,00CC7FE2-08D6-4E0A-A0E2-2B07DD4091EF,Alive,Erasmus MC,University of North Carolina,Germany,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.8,28.04,RNA,,,,,Alive
s996,384B8520-39F7-4466-A4D8-5A787F36FD2C,UNCID_2369849.be5f6966-6a46-4ed2-8fc0-b97b943ad67a.sorted_genome_alignments.bam,76,BE5F6966-6A46-4ED2-8FC0-B97B943AD67A,888ae611-a0de-4248-85e8-05f92e6ee2c4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,82E539C7-C408-41AD-A664-53C79CAA053F,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,20.0,0.18,1.79,15.71,RNA,,,,,Alive
s967,42931DB1-B37F-499F-BD29-A5631099A876,UNCID_2363429.c3ff9063-fcc5-4d2f-9328-dc71d1f232d6.sorted_genome_alignments.bam,63,C3FF9063-FCC5-4D2F-9328-DC71D1F232D6,2d2281a1-d7a9-499f-91b5-cc08013645e4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,A102D5CC-0453-4F91-839B-E3B4C5352273,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.89,35.33,RNA,,,,,Alive
s1094,EC49FE8C-7A45-4A07-BF79-846420FE07E6,UNCID_2388907.5230a88e-698c-4c4c-a54a-d960d2da3214.sorted_genome_alignments.bam,65,5230A88E-698C-4C4C-A54A-D960D2DA3214,39260192-e115-4806-a28d-adc520d77935,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,854E3ECB-459A-4F2F-A4CC-AF89A2CAA80E,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,54.94,RNA,,,,,Alive
s1068,B1219516-BF3C-437D-BF30-69620FABD0E8,UNCID_2375559.d5dcffa7-2d14-4826-a55f-acec4e9b282c.sorted_genome_alignments.bam,25,D5DCFFA7-2D14-4826-A55F-ACEC4E9B282C,ec00f97b-0a0c-49f0-905d-e7ed30183e5a,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,F3EFFB76-35A6-4EFE-AB7F-5F03F4E3A667,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.92,40.79,RNA,,,,,Alive
s1044,DEBF0DE6-694E-4C6F-B4D8-576C4EA7AF5D,UNCID_2380715.d3528468-9e9d-4ff1-b4fd-07ea0694670f.sorted_genome_alignments.bam,35,D3528468-9E9D-4FF1-B4FD-07EA0694670F,57d62b10-0d96-4c72-a108-d877f412842f,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,432F8C5B-EAFF-4080-8123-FC935260FDC4,Alive,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.94,56.21,RNA,,,,,Alive
s954,DDE41DFF-047C-4251-8345-2300CBB27F4F,UNCID_2366760.4d7eab0f-9ff4-49b5-ac79-9bc65a808882.sorted_genome_alignments.bam,65,4D7EAB0F-9FF4-49B5-AC79-9BC65A808882,78bb46f4-060d-45f3-b877-754a9d695798,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,665A3EE4-2118-4C4B-9059-59AB19B3BB43,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Not available,30.0,0.15,1.87,13.7,RNA,,,,,Alive
s953,E0A1A6FF-BB77-4C51-9D38-0DAD075BEE31,UNCID_2362439.9a429f7d-2445-468f-b5e4-cb8ea5059ff2.sorted_genome_alignments.bam,30,9A429F7D-2445-468F-B5E4-CB8EA5059FF2,d206a75d-c939-4d82-a3fd-8a8edf6288ab,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,38A20212-5C57-40A4-85B6-153F07D50BC2,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.83,8.65,RNA,,,,,Alive
s938,48102FB3-5F19-4BC6-BD28-6B8C3D3B2EF0,UNCID_2362168.0ff8209b-37f3-4e71-83e7-06d533bd6aa8.sorted_genome_alignments.bam,47,0FF8209B-37F3-4E71-83E7-06D533BD6AA8,dde27a84-1583-438e-b0bb-1df61829cc54,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,626136F2-F043-4764-BDFA-012CCB96D295,Alive,Roswell Park,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.82,32.82,RNA,,,,,Alive
s968,AF503C15-9CEF-49C9-910B-1481D2CDC493,UNCID_2363570.13a6c447-2479-4719-8f2b-7e0b1a3d2883.sorted_genome_alignments.bam,57,13A6C447-2479-4719-8F2B-7E0B1A3D2883,7d42ff05-1de0-43d3-8a6c-6bbabb582209,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,344629F7-E9FE-4FD7-AA4D-54A1460EDD19,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,27.22,RNA,,,,,Alive
s1081,9FA94EC8-1AA7-467A-9D9F-379C021678D4,UNCID_2381107.1310852c-459c-4abf-a6bf-993fcf3faeff.sorted_genome_alignments.bam,59,1310852C-459C-4ABF-A6BF-993FCF3FAEFF,b64c48bb-ebec-4c03-921e-a859cf893bb3,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1C07233C-211F-4A57-B547-27B13F5EB83D,Alive,Medical College of Wisconsin,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.98,47.21,RNA,,,,,Alive
s1010,43B2BE95-9963-4992-B5B0-3C885FF48E3C,UNCID_2369648.2949f94b-4965-4d54-a1f8-247069ea7298.sorted_genome_alignments.bam,59,2949F94B-4965-4D54-A1F8-247069EA7298,01450144-fb40-44bb-9909-7bd46f3c4d8c,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,037A2CB7-7C40-42A2-AF1A-2322DB978D4B,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.88,23.63,RNA,,,,,Alive
s1087,114D8264-67A5-49F0-BE03-830FF291BCD6,UNCID_2380812.a59acb0f-1136-42ff-abb7-6708dcf51563.sorted_genome_alignments.bam,32,A59ACB0F-1136-42FF-ABB7-6708DCF51563,14576f4d-deea-4111-9047-513bbc69a802,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,CD51E5A0-FB8F-4FD8-9A9E-CDC359A73906,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.15,1.79,18.81,RNA,,,,,Alive
s919,EE3E92F6-3DB3-4C00-9CE2-B8DC69681EA5,UNCID_2357438.38ede230-e4e6-4f03-aeec-1897f4802c78.sorted_genome_alignments.bam,33,38EDE230-E4E6-4F03-AEEC-1897F4802C78,36b0f5a0-42d9-4301-97b9-51b2471c82ee,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,ASIAN,HG19,Primary Tumor,AA56EDC8-14C5-4E63-AA07-D44E977D7DAA,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,43.51,RNA,,,,,Alive
s936,F8CFFDFB-4FB7-4AC6-BC3B-E6486EC19D2F,UNCID_2363867.3838e293-3045-4310-bea8-c94db4a79c3e.sorted_genome_alignments.bam,46,3838E293-3045-4310-BEA8-C94DB4A79C3E,297e13c1-8c36-4729-bac9-142fa718dd04,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,5D2A0ADF-A855-460E-9A9B-BF0924C6F2B8,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.82,21.82,RNA,,,,,Alive
s984,E58EC8DF-06B5-4F62-921D-98589C9DA2DA,UNCID_2373677.4f6640d7-8b5b-4f5c-8379-e27e6c0bce44.sorted_genome_alignments.bam,54,4F6640D7-8B5B-4F5C-8379-E27E6C0BCE44,5512194a-c2f1-4d67-8570-dd6b10d4a348,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,4C76D2B5-686A-4CD4-88CD-292566D6BF17,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.82,40.95,RNA,,,,,Alive
s1074,21DBBC07-8A11-4641-940F-33C341BB901E,UNCID_2375272.e80ab011-e10d-4201-8701-c2824268d455.sorted_genome_alignments.bam,52,E80AB011-E10D-4201-8701-C2824268D455,b0b8c01a-f1fc-4651-8767-49e560278dda,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,A72FF816-CA7C-40BB-B424-2BB941DE5B11,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,21.95,RNA,,,,,Alive
s15189,57DC3B39-7513-4740-A386-ED7376ABB7B6,TCGA-CD-8533-01A-11R-2343-13_rnaseq.bam,48,596432CF-9338-4001-AC07-DBC37E6822E9,c1cf00be-1a34-49aa-b1ab-6b2e26832c19,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,ED155A62-D103-414D-B9E2-3807582D7FBF,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage II,Mar-40,C16.3,C16.3,NO,NO,Complete Remission/Response,38.0,0.16,,202.2,RNA,,,,2011.0,Alive
s8469,3DD03DD0-F5DA-4551-ADD7-0246DF6AC67D,UNCID_2309238.deff8fdc-d2f8-422a-b5bb-57a65241cf51.sorted_genome_alignments.bam,38,DEFF8FDC-D2F8-422A-B5BB-57A65241CF51,688fc346-a14d-4859-8727-057cd0a0b880,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,5F0038DF-DE1C-4C7B-B7CF-544D7C2EAE26,Alive,Dept of Neurosurgery at University of Heidelberg,University of North Carolina,Germany,Astrocytoma,Not available,Not available,Not available,Mar-00,C71.0,C71.0,NO,YES,Partial Remission/Response,30.0,0.17,1.86,15.0,RNA,,,,2007.0,Alive
s8936,636EB46D-7003-40EA-91AC-39F4D4BDF318,UNCID_357545.TCGA-CJ-4876-01A-01R-1305-07.110525_UNC12-SN629_0087_BC03HWABXX.2.trimmed.annotated.translated_to_genomic.bam,57,C71A4961-B4A0-4736-B986-8C95E86F1876,e002c248-0db9-4f94-8590-88dfd6c0c642,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,2EC161E4-9607-42BE-B23F-3F640BB38E04,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2b,N0,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,40.0,0.15,1.8,142.3,RNA,,,,2004.0,Alive
s14651,3F7AAC4F-7A53-48B0-9AAA-E38ABBB31B8E,TCGA-MX-A663-01A-11R-A31P-31_rnaseq.bam,66,F6653DC6-56BE-4913-9FA1-6E4FB984B52C,e9d0aa8b-9ef4-40f7-8254-38fdce349bee,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,9BEED0DC-A68A-4DBC-9D8F-C0EFA5BB6F32,Alive,MSKCC,Canada's Michael Smith Genome Sciences Centre,United States,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage IIA,Mar-40,C16.9,C16.9,NO,NO,Complete Remission/Response,30.0,0.16,1.82,13.71,RNA,,,,2012.0,Alive
s12532,DDDFB702-CB09-4A5F-B023-B31D89EC07A8,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam,41,8358E269-BD6E-4189-86AB-520C84405DAA,0314b145-2f3a-4a90-a580-375b5f0a63a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,1A9E811D-1C60-409C-A7D2-1D58AFA473E9,Alive,Christiana Healthcare,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,,62.17,DNA,88D9F01C-DF4B-4DED-8BAB-76EB446CA357,Not available,Systemic,2011.0,Alive
s4719,79EFB07A-BC92-465D-9833-E33A0DDC031C,UNCID_2090354.f141342e-fbed-4ccf-8e4a-7299397e6e77.sorted_genome_alignments.bam,54,F141342E-FBED-4CCF-8E4A-7299397E6E77,76f98002-e8df-4dfa-926e-8bb2d5114966,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,654F67ED-7295-4360-ADA6-830D4528B17D,Alive,International Genomics Conosrtium,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.85,27.89,RNA,CDF03961-31C6-496D-9E8E-297738256783,Primary Tumor Field,External,2011.0,Alive
s680,249C0C99-7BAC-4781-B3D6-474CDC27C957,UNCID_2603986.43833af2-f61d-45d1-bf14-24ae5ef4c755.sorted_genome_alignments.bam,33,43833AF2-F61D-45D1-BF14-24AE5EF4C755,59f1f860-2f84-4668-ae62-8ca8fa38e47a,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,ASIAN,HG19,Primary Tumor,B254EAA1-215C-4244-BA6F-FD345B455E6F,Alive,University of Southern California,University of North Carolina,United States,Not available,T2,NX,Stage I,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.16,1.74,56.19,RNA,,,,,Alive
s12040,A3165F69-AD11-40B5-8D87-883A70B9985F,UNCID_1457702.93c42359-3615-406b-ad18-8b3f23d8eab5.sorted_genome_alignments.bam,34,93C42359-3615-406B-AD18-8B3F23D8EAB5,efbdedaa-4b02-40ac-b93c-9670c018cf7f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C6534BE5-F333-4AD5-BEC2-7C15C2683FAD,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N1a,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.78,26.28,RNA,248EAEE0-B98C-457E-8E63-94659557E1AE,Primary Tumor Field,Systemic,2007.0,Alive
s15655,E84F34A5-8DF7-4824-92D7-4F53B4BACE58,TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam,59,97962F6C-B2FB-4618-A5A4-7B376714EC62,ebe99910-e9f2-43dc-ad57-ac2f610b60c8,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,8C099F45-3FD6-4966-8CDB-CA4B9288B1A2,Alive,Greater Poland Cancer Center,Harvard Medical School,Poland,Head and Neck Squamous Cell Carcinoma,T3,N0,Stage III,Mar-70,C32.9,C32.9,NO,,Not available,34.0,0.15,1.9,209.7,DNA,0EA129D7-EC68-45C9-9E2C-F70E1A917427,Distant site,EXTERNAL BEAM,2010.0,Alive
s6743,9E546B9E-3E0C-4A79-A18A-227F6CC1C1EB,UNCID_2624941.5e032694-2d7f-4e11-8800-0451ff71e5fe.sorted_genome_alignments.bam,64,5E032694-2D7F-4E11-8800-0451FF71E5FE,49a2fd48-744d-4d88-b9b4-8c778d4f48fd,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,27DAC66A-E5AC-41B4-95E6-4A9F209261EE,Alive,Albert Einstein Medical Center,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1mi,Stage IIB,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.92,32.37,RNA,FBDFCCD6-FB33-4827-8C3D-BA9F05070849,Primary Tumor Field,External,2013.0,Alive
s15325,26B40EB4-08F8-4F94-AF85-1B74C1527C64,TCGA-CG-5716-01A-21R-1802-13_rnaseq.bam,86,DDACE487-7533-4B3B-ADA5-146FA090F56B,49587564-e30f-4f1c-b7b3-fc0989bb1a0a,,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,757546FD-5D3D-4B0A-BF81-06A9316387F8,Alive,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4a,N2,Stage IV,Mar-40,C16.3,C16.3,NO,,Not available,25.0,0.15,1.8,116.2,RNA,,,,2010.0,Alive
s5607,65325ACE-9192-48BF-8AE1-6CDFE01C23E9,UNCID_2173211.43a88718-f528-4d0b-88e6-f2ade6854c53.sorted_genome_alignments.bam,72,43A88718-F528-4D0B-88E6-F2ADE6854C53,06ef6e83-5583-45b9-a0bd-edea68943083,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,9DE14345-B948-4929-AAD7-8ABC4E2D35BA,Alive,Roswell Park,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N2,Stage IIIA,Mar-00,C50.9,C50.9,NO,NO,Not available,80.0,0.15,1.89,6.25,RNA,6AF2B719-A8B2-4E95-BAF5-C4FAFA2FF01A,Primary Tumor Field,Not available,2011.0,Alive
s1863,E460C5AE-4179-406E-A1FD-FB7B1C7403AE,TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.bam,47,C5253C04-01D3-40D9-85A2-155F9D0360C3,3df1b9db-d900-47d2-839d-3900829cb2a9,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,ASIAN,HG19_Broad_variant,Primary Tumor,37A1045E-A566-4BC0-88CA-A54C5426A96D,Alive,ILSbio,MD Anderson - Institute for Applied Cancer Science,Vietnam,Not available,T3,N0,Stage IIA,Mar-70,C15.4,C15.4,NO,NO,Not available,30.0,0.16,,20.64,DNA,DFB1017E-2817-4FC4-ACFA-AE3C38816530,Primary Tumor Field,External,,Alive
s17669,9F102AE1-BA4F-4280-8290-7A435596F060,TCGA-24-0982-01A-01R-1565-13_rnaseq.bam,77,AE158B16-5D93-42D5-A793-3294629AF24D,206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18,679.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,7FEC33CD-6F46-44C7-8204-E0F42B543ABE,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,127.0,0.16,1.8,95.7,RNA,,,,2003.0,Dead
s13735,7940859D-F070-4670-B549-97CD02547ED7,UNCID_1780998.6dca96d6-fdfa-4f4d-91d4-f29ad13c959f.sorted_genome_alignments.bam,58,6DCA96D6-FDFA-4F4D-91D4-F29AD13C959F,3758f4f7-ac2f-4f9d-bee2-526196f8129a,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,AFC23299-5975-4ED8-B9F1-7B8FEF14384B,Alive,Harvard,University of North Carolina,United States,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.2,C18.2,NO,,Not available,28.0,0.16,1.8,90.8,RNA,,,,2008.0,Alive
s6874,BD03C8D5-60AD-4191-8933-073A76C20541,UNCID_1380962.3b042185-867f-492b-a448-7c51e05f9b42.sorted_genome_alignments.bam,63,3B042185-867F-492B-A448-7C51E05F9B42,8f9ad301-6699-4078-a80d-886e40894af7,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,112C8CDD-A187-4D9F-8C71-400848804D32,Alive,Christiana Healthcare,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T1c,N0,Stage IA,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.15,1.83,13.8,RNA,2476582A-72E1-4F42-86D0-721640EC49D6,Primary Tumor Field,External,2011.0,Alive
s10350,9040F3BB-06E9-427F-8D14-A8D1E0A7E527,UNCID_2120847.c9816883-ad45-4699-aafc-14247f03bbff.sorted_genome_alignments.bam,75,C9816883-AD45-4699-AAFC-14247F03BBFF,bf6bab32-98bb-4e09-a7fe-c5c1779a5f60,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,0ADB7C98-7AB2-4D6A-94F8-7D0A166EF1C0,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T3,N1,Stage IIIA,Mar-70,C34.3,C34.3,NO,YES,Complete Remission/Response,30.0,0.17,1.87,29.98,RNA,,,,2002.0,Alive
s14874,4A46244E-AC69-4C2D-B521-8BB0EC7D8B48,_1_TCGA-HU-A4H2-01A-11R-A251-31_rnaseq.bam,58,C563F7E8-E92A-446A-ABDB-0AA680D50E8C,7b594344-573d-46a0-b735-6727f6f15585,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,79787A68-78E6-4FBE-9FA8-FFF839E9534D,Alive,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N3b,Stage IIIB,Mar-11,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.16,1.81,73.53,RNA,,,,2011.0,Alive
s17646,15E0CF4F-79FE-4E96-9D59-9CC8B1D5FC36,TCGA-61-2016-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,51,A391B870-B6FB-4CA8-B425-2331FCEAE442,512de609-757b-42be-8b30-c414f71af422,36.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,B15D7B36-C394-4BA4-A896-3E8BEB2F8DB0,Dead,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,100.0,0.14,1.8,258.0,RNA,,,,2006.0,Dead
s4309,55F2EB0B-B6CA-49B7-9DF3-51D3F621CA5D,UNCID_1636626.39b1ee4d-b57a-44d5-8b14-20b02f878123.sorted_genome_alignments.bam,63,39B1EE4D-B57A-44D5-8B14-20B02F878123,233e947a-d5e2-48e5-a8ce-5da1abb20681,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,42199E5A-9F4F-4445-9E6E-114D47BA67FA,Alive,Duke,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.77,74.9,RNA,18494A76-FF86-479E-83CD-787AAD3F37D0,Primary Tumor Field,OTHER: SPECIFY IN NOTES,2007.0,Alive
s17400,C2B1D7E5-92F6-426D-95D2-58B663607539,TCGA-59-2352-01A-01R-1569-13_rnaseq.bam,78,A209A8F4-9462-4ADE-BE57-CAAEC54999CB,758e6b52-062e-4ca0-84d1-ea38477414ac,286.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,2892B681-6001-4124-AE86-3363BE75463B,Dead,Roswell Park,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,127.0,0.15,1.8,582.0,RNA,,,,2002.0,Dead
s12436,8630FB4A-1187-4A23-BED6-A0E99791B796,UNCID_1560058.39BC85C4-E9AC-40E3-8932-7AA4AFB27B84.sorted_genome_alignments.bam,81,39BC85C4-E9AC-40E3-8932-7AA4AFB27B84,7746be87-7ad0-48a7-84fb-08a81b220bdb,533.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E1C4D037-D70F-4AB1-BB34-554538C934CD,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,NX,Stage IVC,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,30.93,RNA,675B6EE0-EFB4-431B-9957-8A246635A078,Regional site,Systemic,2004.0,Dead
s10759,C7601721-DA6E-403A-9B43-7971F6513153,G25789.TCGA-78-7535-01A-11D-2063-08.1.bam,45,FA8844F8-C4B6-487A-8187-E30C12A7A453,46592b7b-6968-42a6-83af-0917c9f4a9a5,949.0,Lung Adenocarcinoma,Not available,WGS,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,C0A8C73C-35BA-4724-B13A-9A9986AF36C0,Dead,Prince Charles Hospital,Broad Institute of MIT and Harvard,Australia,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,31.0,0.05,,314.3,DNA,,,,2000.0,Dead
s880,9E475465-0B00-4BD0-AC48-D592FDB79AA9,UNCID_2622674.c677782e-02d1-42cf-ba27-cc1d1b90b915.sorted_genome_alignments.bam,65,C677782E-02D1-42CF-BA27-CC1D1B90B915,ecdd0e44-0add-4a08-a3f8-ab2f51df7afd,1130.0,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,DBAD19A2-7A1C-4D24-8805-C27C8EB6D859,Dead,Asterand,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,,Not available,30.0,0.15,1.78,11.48,RNA,,,,2008.0,Dead
s4913,6F366C26-4E6E-4BDC-B588-45299BE8447D,UNCID_2251816.a36f18b0-3978-4a46-bb1c-7c0839f492e9.sorted_genome_alignments.bam,71,A36F18B0-3978-4A46-BB1C-7C0839F492E9,ab7adf74-6e87-4117-9742-54e323348e06,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,7AC409D7-3F50-4228-9767-6BBF38A8D767,Alive,Christiana Healthcare,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,YES,,Not available,400.0,0.16,1.92,81.26,RNA,68758F4E-11D6-437F-A057-33C391965EF2,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s13317,FBD0FE4C-4E57-473D-A9DD-89782181FAE2,UNCID_258870.TCGA-AA-3554-01A-01R-0826-07.100603_UNC3-RDR300156_0007_61MM1AAXX.7.trimmed.annotated.translated_to_genomic.bam,62,F6601DE6-113D-491F-9F00-F88A2042983A,ba49b428-246d-46d2-b549-39a5fc8f7003,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,FA826D89-3485-4D32-8D90-BA4B16C519D5,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.2,C18.2,NO,,Not available,105.0,0.16,1.8,517.3,RNA,,,,2008.0,Alive
s15091,540365F8-E13A-45B5-A33B-2C97D6359044,_1_TCGA-HU-A4G2-01A-11R-A251-31_rnaseq.bam,45,28FA0322-5B05-46FF-913D-738A24CDF255,3b17c66a-34ae-4b10-b907-4464d6d58383,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,C2C1E3D8-056A-4129-BD1C-40F7B88AEED2,Alive,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Adenocarcinoma  Diffuse Type,T3,N1,Stage IIB,Mar-45,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.17,1.83,61.71,RNA,,,,2011.0,Alive
s10399,B6403A45-AECC-4476-A87B-036B933A7A45,UNCID_1066239.b45df1ad-f756-4ec6-ae76-264dd51fae7e.sorted_genome_alignments.bam,65,B45DF1AD-F756-4EC6-AE76-264DD51FAE7E,d11c4976-ba19-4616-be79-d1e321c26d07,329.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,261A8506-2F74-4BEB-97EC-1818FA824DB6,Dead,Fox Chase Cancer Center,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N2,Stage IIIA,Mar-70,C34.1,C34.1,NO,,Not available,55.0,0.14,1.8,159.8,RNA,4F868CA9-377D-4FA6-9914-81820CC45C60,Distant site,EXTERNAL BEAM,2009.0,Dead
s17696,83D0F93F-D442-496A-87F0-0B07A173C362,TCGA-36-1576-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,76,55B6BD7C-E77D-4019-93E9-B5410E4807B2,3445c524-5a37-40b6-8614-956d76eed939,,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,Not available,GRCh37-lite,Primary Tumor,24FFA457-5765-43C1-8CDD-B50A31DC5B56,Alive,BC Cancer Agency,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,118.0,0.15,1.8,590.0,RNA,,,,2006.0,Alive
s4119,D5404FA7-88FC-459E-9612-6CE1A94E965B,UNCID_2621203.6eb18bd6-15f9-42fb-a8d0-91c7fb0342ff.sorted_genome_alignments.bam,59,6EB18BD6-15F9-42FB-A8D0-91C7FB0342FF,9bf4e7bb-6aa9-4be8-a7c3-e630ecff4dce,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,F328DE54-F9C2-4280-8D37-35629B1148B1,Alive,University of California San Francisco,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.17,1.9,22.88,RNA,,,,,Alive
s3052,37547265-5EFC-46E1-AA30-CAE22EF73336,UNCID_2633633.9e99dced-8649-4a7e-bba9-ccde95cc4045.sorted_genome_alignments.bam,59,9E99DCED-8649-4A7E-BBA9-CCDE95CC4045,aaa55de1-8f53-4b56-ba0a-67cff909cf81,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,1AD5FFD6-8CC7-4638-9915-0D1A69311C9E,Alive,University of Sheffield,University of North Carolina,United Kingdom,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.9,C67.9,NO,NO,Complete Remission/Response,20.0,0.15,1.73,38.65,RNA,,,,2011.0,Alive
s10077,8A33C586-703C-4354-9BDE-CAAB929FCC59,G47088.TCGA-92-8064-01A-11D-2244-08.2.bam,58,0E6654C9-CD5E-4F94-A6D4-54F2BB16DE1F,dc6ceece-efaa-4b9d-9e12-d35863d7a902,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,014AD75E-86D2-423F-B9D3-84657D459A28,Alive,Washington University - St. Louis,Broad Institute of MIT and Harvard,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2b,N0,Stage IB,Mar-70,C34.1,C34.1,NO,NO,Complete Remission/Response,35.0,0.05,,406.33,DNA,,,,2011.0,Alive
s9761,BE047178-75F4-4269-8531-B33DDB083C4A,UNCID_1174736.e5276782-9ac4-454d-a7b3-72d6c12fbd5d.sorted_genome_alignments.bam,74,E5276782-9AC4-454D-A7B3-72D6C12FBD5D,a5d34ea3-9362-4233-8d9e-1892839179b2,334.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,309083B8-041E-4C3D-BCF2-FA3E4F671C10,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.14,1.8,106.3,RNA,,,,2007.0,Dead
s2762,7018B23A-A0C4-4A35-8442-DF82992D5927,UNCID_1327445.57eda6ed-26b0-4bf6-98ad-80f4872b9832.sorted_genome_alignments.bam,74,57EDA6ED-26B0-4BF6-98AD-80F4872B9832,3d644eaf-82fc-4bc7-93b7-3e600e8c6511,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,B02C03B6-24AA-42D3-9310-741DE1EF0D30,Alive,BLN - Cleveland Clinic,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T2,NX,Stage II,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.17,1.79,44.57,RNA,317866A6-A485-479A-B7D1-BA2022C96DA8,Regional site,External,2011.0,Alive
s15664,6FFA421C-0F47-4D94-87B2-51F7FE1D6C5C,UNCID_1483080.97891596-1e24-435b-aec0-29bee5f3cb04.sorted_genome_alignments.bam,38,97891596-1E24-435B-AEC0-29BEE5F3CB04,4cffea0b-90a7-4c86-a73f-bb8feca3ada7,351.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,665D4BFF-603C-497B-816F-C98784665D0F,Dead,University of Pittsburgh,University of North Carolina,,Head and Neck Squamous Cell Carcinoma,T2,N3,Stage IVB,Mar-70,C09.9,C09.9,NO,,Not available,38.0,0.15,1.8,283.3,RNA,,,,2006.0,Dead
s2753,9ED2F8D5-9C80-4457-8404-E0B64257E3A1,UNCID_1209803.968143b4-2bc1-4c77-88e7-a907a7cd018c.sorted_genome_alignments.bam,56,968143B4-2BC1-4C77-88E7-A907A7CD018C,c6227d39-d9e8-4e28-9e70-d7f720ab25e4,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,FBAD20BA-EE08-4D46-825B-870126AAD539,Alive,MD Anderson,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,N0,Stage II,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.17,2.11,61.24,RNA,,,,2009.0,Alive
s14861,0ED38825-CA0D-4C51-B6BA-7B29CA0B7C13,_1_TCGA-BR-8361-01A-11R-2343-13_rnaseq.bam,71,7AFB9E90-6E93-420F-8325-C77FCA6E661A,86cbca52-29bd-4b88-a203-e8b9a072bd4b,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,F05E8A2F-3DB9-41C4-9E4D-CD898AB53AA4,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4b,N2,Stage IIIC,Mar-40,C16.1,C16.1,NO,,Not available,34.0,0.14,,327.5,RNA,,,,2012.0,Alive
s15279,3CAFA026-E7B9-45A3-9164-F776D870A365,_1_TCGA-CG-4449-01A-01R-1157-13_rnaseq.bam,81,322FEC81-00AF-45DA-8769-B1339A040F46,10b5774d-7079-4b4b-b824-f4745f5598c7,,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina GA,Stomach,Not available,GRCh37-lite,Primary Tumor,E98BD336-1B0D-4655-A537-2A5DAE99114D,Alive,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach Intestinal Adenocarcinoma Mucinous Type,T2,N1,Stage II,Mar-80,C16.3,C16.3,NO,,Not available,35.0,0.16,1.8,110.3,RNA,,,,2007.0,Alive
s10678,68B0DECB-6CD6-4429-95AF-E1988D77930E,UNCID_1094301.17a5a6af-dca6-47dc-912a-7ac0c226da89.sorted_genome_alignments.bam,84,17A5A6AF-DCA6-47DC-912A-7AC0C226DA89,009be09b-f9f6-43b7-8f45-4a648f8123ce,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,E4CB66F4-E847-40BF-AF14-20A3867A1C35,Alive,St Joseph's Medical Center (MD),University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.3,C34.3,NO,,Not available,107.0,0.15,1.8,300.3,RNA,,,,2009.0,Alive
s14644,1C4E2785-C364-4D31-8894-05947C517D55,TCGA-D7-A6EY-01A-21R-A31P-31_rnaseq.bam,72,658225D0-77CD-4F11-9DA4-D9011167D850,73bd696b-0f35-4f70-8888-8153b1ba9ee4,348.0,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,F6695E09-3165-4253-A3AA-F363FACFD4D0,Dead,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N3a,Stage IIIB,Mar-11,C16.3,C16.3,NO,NO,Progressive Disease,30.0,0.16,1.85,29.45,RNA,,,,2013.0,Dead
s1949,5B884AF8-BDDA-4F76-954D-D48A874D8FF2,TCGA-X8-AAAR-01A-11R-A406-31_rnaseq.bam,69,623CD7CB-FD58-46B5-A0C5-19C474B66AC8,caf9b681-af70-4a6d-a871-c45926220de5,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,5A598638-59C7-4233-B4A9-0A8D2C6FA229,Alive,St. Joseph's Hospital Arizona,Canada's Michael Smith Genome Sciences Centre,United States,Not available,T1,N1,Not available,Mar-40,C15.5,C15.5,NO,NO,Not available,30.0,0.17,1.87,28.87,RNA,,,,,Alive
s16074,7290AA43-D24C-4DE1-9652-3D06179192BC,UNCID_1482750.95164448-cf02-457f-9b18-f0a19d674c78.sorted_genome_alignments.bam,43,95164448-CF02-457F-9B18-F0A19D674C78,31202ace-6480-46db-8e0d-b4c64149e326,,Head and Neck Squamous Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,2840E28D-196F-40D3-89C0-69D083B8F8BB,Alive,Johns Hopkins,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N0,Stage III,Mar-70,C02.9,C02.9,NO,,Not available,32.0,0.15,,130.2,RNA,,,,2011.0,Alive
s8723,1A17695B-59A7-40A0-83ED-BE2194A16916,UNCID_2400656.721a570e-56ea-4054-98c1-9ac2105c33ca.sorted_genome_alignments.bam,58,721A570E-56EA-4054-98C1-9AC2105C33CA,b3f0dece-94e8-4eaf-91bc-4b3f4dae12d2,240.0,Brain Lower Grade Glioma,Not available,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,AB72A537-9CFA-4DCA-B9BD-1B130FCBFF25,Dead,Huntsman Cancer Institute,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,,Not available,30.0,0.16,1.69,15.93,RNA,C86B2261-01A0-4F4A-8193-6F9792AC7062,Primary Tumor Field,External,2012.0,Dead
s11631,FB713325-515A-4BE7-80FE-8CDA6A1114D8,UNCID_2585196.cfca77a9-fcfb-4ab5-b969-2ae55a0cbd32.sorted_genome_alignments.bam,77,CFCA77A9-FCFB-4AB5-B969-2AE55A0CBD32,5cbf0134-023b-4bd0-97da-eb836ccbc729,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,853D3A6F-43CB-490A-9215-C5F415DBE33B,Alive,Moffitt Cancer Center,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1a,NX,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.17,1.9,24.61,RNA,,,,2006.0,Alive
s5868,72BD6964-5278-4771-99C1-6E32521030D5,UNCID_1148055.fb0cd718-5300-4447-9740-a63308f65d92.sorted_genome_alignments.bam,56,FB0CD718-5300-4447-9740-A63308F65D92,e17c565c-9857-4df3-a352-903b53093c85,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,630613D2-682F-4A1A-B1FA-95320FB9A9B7,Alive,MSKCC,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N1,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.14,1.73,19.85,RNA,,,,2007.0,Alive
s6440,0D82859A-8DF8-4C6B-8E4B-C99FCC2CB7A9,UNCID_2622524.c924c2a8-ab41-4499-bb30-79705cc17d45.sorted_genome_alignments.bam,62,C924C2A8-AB41-4499-BB30-79705CC17D45,427d0648-3f77-4ffc-b52c-89855426d647,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E355913A-6E4C-4D63-8A53-8BE4C5B003B8,Alive,Columbia University,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.82,42.45,RNA,,,,2011.0,Alive
s1858,5A835C09-F956-4F27-A119-6B68C9473CA4,TCGA-LN-A49R-01A-11R-A24K-31_rnaseq.bam,46,6B234444-AF2D-4266-8466-8B729DA2769C,4c9fb311-0860-4a04-a2f6-79558ac1d98f,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,ASIAN,GRCh37-lite,Primary Tumor,74585CFD-4536-4EF9-89E6-B2D133BB6A0C,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Not available,T3,N1,Stage III,Mar-70,C15.5,C15.5,NO,NO,Not available,30.0,0.16,1.86,59.99,RNA,360DFA04-5467-41E8-8F37-E39FF159FECE,Primary Tumor Field,External,,Alive
s9687,BD37EB8A-C260-418A-BE0E-94EE2DE7FD4A,UNCID_368682.TCGA-B0-5085-01A-01R-1334-07.110614_UNC11-SN627_0104_AD0CV3ABXX.5.trimmed.annotated.translated_to_genomic.bam,76,F3A4A31C-EC26-4D81-A721-616A7A22F780,62c6edc7-170d-4825-ab81-f88b14013cc5,770.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,4B318DA4-400C-4A00-9258-CC4D114813F6,Dead,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.14,1.8,48.3,RNA,,,,2005.0,Dead
s1624,17927937-E602-4031-B90B-28FB55425F5E,TCGA-IG-A3YC-01A-11R-A24K-31_rnaseq.bam,62,03CAD6EC-004B-4B3C-A165-A7E8860FB82E,6a05288e-d051-40a5-9f4e-864ab806a5dc,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,C754C363-924A-404A-9D60-4CA2A3930D2A,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Not available,T3,N1,Stage IIIA,Mar-70,C15.5,C15.5,NO,,Not available,30.0,0.17,1.76,51.34,RNA,,,,,Alive
s16304,2BC4CE8C-00BF-4A30-963D-A8EA6F1C2232,UNCID_2347707.fcd4b575-d9fd-4a7d-967c-994144b913c4.sorted_genome_alignments.bam,45,FCD4B575-D9FD-4A7D-967C-994144B913C4,a563109d-0990-4bdc-8bd7-6766d1eadbdc,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,906D57C3-26E7-45F6-BE6F-A8BABC20403A,Alive,Not available,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2b,Stage IVA,Mar-70,C06.0,C06.0,NO,NO,Complete Remission/Response,20.0,0.18,1.96,65.15,RNA,079FC6FD-8919-446F-A25B-BAC1A516F817,Not available,External,2008.0,Alive
s10852,4F0967C9-E1CD-4EBA-B4A2-0B21F3E2A3DF,UNCID_1366131.2cb8a95d-20c3-4623-9b4d-b06b2a494b18.sorted_genome_alignments.bam,76,2CB8A95D-20C3-4623-9B4D-B06B2A494B18,ef03654a-dcf1-41ff-a67e-4f3fbf9ba807,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,7E1638D3-F134-4DC8-BECC-9F4D49D83024,Alive,Washington University - St. Louis,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T1a,N0,Stage IA,Mar-55,C34.1,C34.1,NO,,Not available,40.0,0.13,,13.2,RNA,,,,2011.0,Alive
s16196,6D564719-34A3-4B79-BF57-A5C8F73D7436,TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam,68,9988EB07-01F6-4F83-8699-BB63E0525F08,d89b1fd6-bef4-4803-8ed3-3b442be600b6,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,GRCh37-lite,Primary Tumor,B4A36114-80D3-4F28-B85A-077DC31EB485,Alive,MD Anderson Cancer Center,Baylor College of Medicine,,Head and Neck Squamous Cell Carcinoma,T3,N0,Stage III,Mar-70,C32.9,C32.9,NO,,Not available,39.0,0.08,1.9,341.0,DNA,,,,2000.0,Alive
s14304,CDEC514C-A32F-496A-81C5-CDE0EC0A3B5C,G26396.TCGA-41-5651-01A-01D-1696-08.1.bam,59,5FD77BA9-5015-4D8B-86A0-582E5C76BDD6,c184c3ca-7ad3-4202-b108-cb9fd5f5d947,,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,90F74516-FB74-4D3F-9D73-5D2BEE2ED381,Alive,Christiana Healthcare,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,69.0,0.05,1.9,350.03,DNA,2F9DB4F3-03C0-4A60-9626-B48FD7AC6AB9,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s17907,37363F7D-3F3A-466B-A249-B5AB2453C9A6,TCGA-13-0724-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,72,FC6DF206-8C77-486C-BC38-06B6CF20139D,a9abe7a7-4126-414b-87d2-a6d25abcf1fa,83.0,Ovarian Serous Cystadenocarcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,30ABE357-43D0-434C-99D1-AFFE0FD047D8,Dead,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,84.0,0.19,1.8,294.0,RNA,,,,2002.0,Dead
s16664,7DAA763B-95EA-49A7-88EC-1C007336E23B,UNCID_2637163.be86bc67-ccbb-4565-adc3-4577b8067a33.sorted_genome_alignments.bam,66,BE86BC67-CCBB-4565-ADC3-4577B8067A33,431a72e1-ea03-4e40-89c4-2f02d454c897,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,373CA39A-AC3E-4129-95AE-18EED3237CAC,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T2,N0,Stage II,Mar-70,C22.0,C22.0,NO,YES,Not available,20.0,0.17,1.94,74.34,RNA,,,,2010.0,Alive
s11337,99148000-BE38-4DA1-AEAA-4B0271725662,TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam,64,2D5C6425-E3F4-4389-9DDF-FDE694B4227E,0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,AD66185F-983D-4416-B705-25D3D4D8B5A5,Alive,Christiana Healthcare,Harvard Medical School,United States,Lung Mucinous Adenocarcinoma,T3,N0,Stage IIB,Mar-80,C34.3,C34.30,NO,,Not available,34.0,0.16,1.9,72.0,DNA,,,,2010.0,Alive
s8780,F87B5C04-3815-4EF0-B147-7DD243BC3E74,UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments.bam,37,80DAC2DB-4E32-4854-BA10-2D9AA059BF45,48314732-5d1c-43e6-9878-5b58dfaeb06a,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,4A579925-CCA7-4212-9299-843BB6EB0EB7,Alive,Case Western - St Joes,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.9,C71.9,NO,,Not available,37.0,0.16,,45.2,RNA,,,,2010.0,Alive
s8628,2946CABA-E127-4562-8315-6DC8D5C5AF3A,UNCID_1671011.5ee6524b-9289-45a8-949e-ba0ce44913fe.sorted_genome_alignments.bam,60,5EE6524B-9289-45A8-949E-BA0CE44913FE,fea46eef-6b7f-44c3-93bf-2dec16bdeb79,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,7B8F26AB-AAD4-4191-9C1E-188A3A7A220A,Alive,Case Western - St Joes,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,,Not available,33.0,0.15,,166.2,RNA,,,,2009.0,Alive
s4923,61A1B4B9-04B7-412C-AED5-A8BA1E20F715,UNCID_251958.TCGA-AP-A051-01A-21R-A00V-07.100903_UNC3-RDR300156_00028_FC_62ELKAAXX.1.trimmed.annotated.translated_to_genomic.bam,69,520AC0A0-A49F-4990-8A49-DFE312361E30,b045f24b-f822-4df9-9ffa-47308edcec8c,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,417CFF62-B034-4197-9CFD-E640D55F3094,Alive,MSKCC,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.14,1.83,86.66,RNA,6E4976E1-B594-41D1-B848-4AC8D29A8A80,Primary Tumor Field,EXTERNAL BEAM,2003.0,Alive
s9162,E2CE6973-54D1-4E7B-88F1-CB684419FF11,TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.bam,40,AAD8C8D6-D828-4AAC-9CFB-CEE893E36850,1e417b93-837d-4110-9090-239eb82c3e20,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,8CD2BBCD-3CE9-4B57-99DA-895B82300AF8,Alive,MSKCC,Baylor College of Medicine,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.14,1.9,68.77,DNA,,,,2006.0,Alive
s9198,4DB03257-6DB6-4CAE-81BD-9AD670EE48F2,UNCID_1180417.67a7b43d-fa7b-4f9a-a948-7d2214f28d03.sorted_genome_alignments.bam,37,67A7B43D-FA7B-4F9A-A948-7D2214F28D03,ea854858-1dad-4b01-8e58-f19e6a7c41a3,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,F8BC0763-5043-4B7D-9045-797D47C46066,Alive,NCI Urologic Oncology Branch,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.14,1.7,58.3,RNA,,,,2008.0,Alive
s11191,598AAD1E-3CFB-45BA-8EAE-2CA8EE055ACA,UNCID_1990581.da823ce3-fb4c-4626-824d-deef668836cf.sorted_genome_alignments.bam,52,DA823CE3-FB4C-4626-824D-DEEF668836CF,c0c879f7-c332-4d31-9f7e-a3bf361b36ee,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,A9C846B1-9EE0-4F96-85BF-B7DD53C4230C,Alive,Washington University - NYU,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T1a,N0,Stage IA,Mar-55,C34.1,C34.1,NO,NO,Complete Remission/Response,30.0,0.16,1.84,7.73,RNA,,,,2012.0,Alive
s3697,FE81A4FA-BB70-4227-9289-72FD3E0EDF50,UNCID_2043839.131d97b1-b0d3-41d1-8fba-aaaa9eabdf9d.sorted_genome_alignments.bam,53,131D97B1-B0D3-41D1-8FBA-AAAA9EABDF9D,f7238e82-a394-4a7c-8514-6241d0aa17e3,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,1E8F6337-5129-4F23-ABE7-F158028E434A,Alive,Asterand,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.18,1.85,51.1,RNA,3C8C9090-3CAF-48E7-B83F-82C59C72D62E,Primary Tumor Field,External,2012.0,Alive
s11179,82EF62DD-6444-46B2-837E-CD1D93EC7FA5,UNCID_1371310.937a163b-b469-46a0-87b8-6d7c7e6105d7.sorted_genome_alignments.bam,62,937A163B-B469-46A0-87B8-6D7C7E6105D7,0d0d83d9-d558-4d38-977b-6f1b2471beda,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,85E8A3BF-0536-4556-A40F-8A523C04B337,Alive,Asterand,University of North Carolina,Russia,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-40,C34.3,C34.3,NO,,Not available,30.0,0.14,,168.2,RNA,29EF3999-EA2A-4E8E-A0AF-09FF97FDCE95,Regional site,External,2011.0,Alive
s4722,29BD6D0C-B51B-4B39-A07D-C7683C4B39A9,UNCID_2191871.4da7543e-f58a-46f1-bf94-834d4ce4cbff.sorted_genome_alignments.bam,65,4DA7543E-F58A-46F1-BF94-834D4CE4CBFF,71ed2681-79bb-4ffb-985c-6d3cf18e9168,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,C27F13AB-69DD-403C-B81E-FC4BC4BFA329,Alive,University Health Network,University of North Carolina,Canada,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.71,87.51,RNA,1372A0A7-6B53-46D2-BB13-53047695D68B,Primary Tumor Field,Not available,2010.0,Alive
s7913,1CB7AEC6-47B4-4ABA-94AE-A7E137978E75,UNCID_1238212.30f9edcc-a7d4-40fd-82d9-238fcd6c08b0.sorted_genome_alignments.bam,79,30F9EDCC-A7D4-40FD-82D9-238FCD6C08B0,f9e36bc2-484f-48e8-82ba-99026957277a,469.0,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19,Primary Tumor,E358B11D-2A35-45AE-8910-AE2DC06D39F4,Dead,University of Pittsburgh,University of North Carolina,United States,Not available,T4b,N0,Stage IIC,Mar-20,C44.4,C44.4,NO,YES,Not available,30.0,0.17,1.81,31.75,RNA,,,,2006.0,Dead
s10265,AD1B53FC-DB85-47E9-BB7E-B97E77365D39,UNCID_1033806.432b9ce2-3ef5-4343-896f-bc91c59035fd.sorted_genome_alignments.bam,58,432B9CE2-3EF5-4343-896F-BC91C59035FD,188fe74b-a62b-47a0-9069-5c3a2837ee05,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,A2BD3774-B4B4-4419-83A4-D935C285419C,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2a,N1,Stage IIA,Mar-70,C34.1,C34.1,NO,,Not available,33.0,0.15,,165.2,RNA,,,,2010.0,Alive
s18139,584F214C-2E71-4CA4-BD68-7E15B85973DD,TCGA-61-1900-01A-01R-1567-13_rnaseq.bam,51,92ADF6A1-4880-4EE4-8EBE-09A943DBFE04,ef653772-e5d2-46ec-8610-f81d75d7353c,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,BLACK OR AFRICAN AMERICAN,NCBI36_BCCAGSC_variant,Primary Tumor,FB634D39-A4FE-493E-A982-2E360E69CBD2,Alive,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,101.0,0.15,1.8,337.0,RNA,,,,2008.0,Alive
s17338,821079B1-BD52-4DE3-A836-5234F562D8FA,TCGA-23-1027-01A-02R-1564-13_rnaseq.bam,48,EDBC81A6-2593-45C5-8131-3C4615D1807F,c9e58844-9d61-44a2-aee6-1760bc19711b,976.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,DDB8C0DD-C3DF-4B78-850D-56B0644E12D7,Dead,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,103.0,0.17,1.8,361.0,RNA,,,,2005.0,Dead
s2826,30C77F2F-8285-4948-9496-8947FE1A2FFF,UNCID_2512540.347ce226-e621-4492-a821-c990b5ef4ff3.sorted_genome_alignments.bam,78,347CE226-E621-4492-A821-C990B5EF4FF3,95520295-90d3-4b4e-86b6-4bd856723315,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,E02F0582-9183-4E63-BFD5-48F7C1565DAF,Alive,Spectrum Health,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,Not available,Stage II,Mar-20,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.15,1.87,83.93,RNA,,,,2013.0,Alive
s11065,F6BAD4C4-12EE-42C4-B0A8-517E24DA06B4,UNCID_1573378.8fabb97c-5921-4156-98c0-86bdd642c612.sorted_genome_alignments.bam,85,8FABB97C-5921-4156-98C0-86BDD642C612,f0c94f68-bfd9-45cb-b4fd-8bb1ae4e9a2b,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,96BDAFE1-B0FB-4126-9734-1374D615EF6D,Alive,Washington University - Cleveland Clinic,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T2b,Not available,Not available,Mar-55,C34.3,C34.3,NO,NO,Complete Remission/Response,26.0,0.14,,17.2,RNA,,,,2012.0,Alive
s2292,E4A46139-5EED-41C6-9B4C-8020045A08F1,UNCID_271167.TCGA-AG-3892-01A-01R-1119-07.100819_UNC8-RDR3001640_00015_FC_6293BAAXX.4.trimmed.annotated.translated_to_genomic.bam,57,0F36882B-28F4-4750-B669-FFC53DFBF27B,ded3feb2-1079-4520-a7ca-f5b5fc73d7c5,,Rectum Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,D5B6919D-5654-486F-95B0-D89CB1893614,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T1,N0,Stage I,Mar-40,C20.9,C20,NO,,Not available,128.0,0.14,1.8,348.3,RNA,,,,2009.0,Alive
s16967,2770301D-1AAD-4532-AFC3-845135FE5CB0,UNCID_2659101.89ad7202-565f-4459-a1ca-946dd27d07b7.sorted_genome_alignments.bam,51,89AD7202-565F-4459-A1CA-946DD27D07B7,5eaaf7ae-36af-4fb4-8940-e0861983ceb0,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,D7116164-D537-4B2D-B699-EC091C094363,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,10.0,0.16,1.82,28.82,RNA,,,,2011.0,Alive
s14770,EA4575D5-175F-4D32-ABB0-CDC560C766E8,TCGA-D7-6528-01A-11R-1802-13_rnaseq.bam,70,8B425D92-11E6-4DCE-914E-5A2F00603719,35496e4e-598f-4ffc-b11e-8edaeb676079,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,DF817250-9A2C-42E8-AD90-0D9E13FE37B3,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T2,N0,Stage IB,Mar-11,C16.2,C16.2,NO,,Not available,39.0,0.14,1.8,252.2,RNA,,,,2010.0,Alive
s16030,CD1138AB-45A7-4DA9-A78D-142E2E75F255,TCGA-CN-4737-01A-01D-2266-10_Illumina.bam,19,878A7FE7-20FF-4651-9587-B4D6FD42E929,1f744ada-6de1-446d-b62c-76a7fc8b40af,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,GRCh37-lite,Primary Tumor,BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA,Alive,University of Pittsburgh,Baylor College of Medicine,,Head and Neck Squamous Cell Carcinoma,T2,N2b,Stage IVA,Mar-70,C02.9,C02.9,NO,,Not available,40.0,0.05,1.9,142.0,DNA,8FE09FD3-4235-4AE7-8658-F827D949267A,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s6339,0937D1DA-020E-4E55-A6A5-5B304F969EEC,UNCID_1138621.ddb62dc3-293b-4021-905a-83ae10aa0f8e.sorted_genome_alignments.bam,50,DDB62DC3-293B-4021-905A-83AE10AA0F8E,00807dae-9f4a-4fd1-aac2-82eb11bf2afb,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,699D9E14-0968-4773-B077-17DB941F5C38,Alive,Walter Reed,University of North Carolina,,Other  specify,T2,N1mi,Stage IIB,Mar-01,C50.9,C50.9,NO,,Not available,30.0,0.14,1.85,23.52,RNA,,,,2005.0,Alive
s14444,05602AB2-5B11-4B4E-AB1A-1790C7D7AA3A,_1_TCGA-BR-8682-01A-11R-2402-13_rnaseq.bam,52,C3DF7B7C-64A2-4925-A8C0-2E4C6DC82AFF,d5efcde2-21e6-4071-9aa4-3c5688a45b3f,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,4E6BBC3C-BB9E-46C0-8B22-60F9725DB516,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach Intestinal Adenocarcinoma Mucinous Type,T4a,N0,Stage IIB,Mar-80,C16.3,C16.3,NO,NO,Complete Remission/Response,37.0,0.15,,139.2,RNA,,,,2012.0,Alive
s10922,81381352-396C-43B2-8946-80D16EB99A9A,UNCID_1091612.ddb17f24-f233-40dc-bbbd-731e50d4fce4.sorted_genome_alignments.bam,68,DDB17F24-F233-40DC-BBBD-731E50D4FCE4,fc79086c-af9a-4c27-b074-f7050b6f3381,1171.0,Lung Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,284DE41B-6AD8-4C29-9ECA-9A841CD7C3B7,Dead,Prince Charles Hospital,University of North Carolina,Australia,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,28.0,0.15,1.6,67.2,RNA,D46F3ED7-D9F7-4800-9AFF-2D7226581603,Primary Tumor Field,EXTERNAL BEAM,2005.0,Dead
s10789,FD2A1C20-3ED6-4057-8FB5-4027CE0EEC74,TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.bam,42,80170E98-4886-4A34-BC88-F2B2F84743B2,e1c55bac-bb41-4964-add5-ecd6ba04b58d,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,180EB213-0DDC-4F10-AB0E-B3AF92CDE3C3,Alive,University of Pittsburgh,Harvard Medical School,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,,Not available,29.0,0.15,1.9,416.7,DNA,47FFDBD3-4E1B-4E78-B229-1E3CF0B787D6,Primary Tumor Field,EXTERNAL BEAM,2007.0,Alive
s3878,A3899D5F-0C33-4071-AFC8-440434CDB7CC,UNCID_2245991.dce52b98-298c-4980-ba8b-3791b6528d4c.sorted_genome_alignments.bam,64,DCE52B98-298C-4980-BA8B-3791B6528D4C,5447a0e0-80ca-40fb-8233-504fde51f22c,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,F6E93A76-4E34-438A-9092-7B3E173E116C,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-40,C61.9,C61,NO,YES,Stable Disease,30.0,0.17,1.89,37.83,RNA,,,,2012.0,Alive
s1321,0C4F8173-42C9-497B-83CC-DD005406E685,UNCID_2633119.d8259ddb-5f41-43ea-889c-1e7dba9d32bc.sorted_genome_alignments.bam,39,D8259DDB-5F41-43EA-889C-1E7DBA9D32BC,ee2c9743-eaa1-4f0d-8d35-e96686ac3913,829.0,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,24825A46-BCF8-4E14-A3A5-E2486C54E247,Dead,Barretos Cancer Hospital,University of North Carolina,Brazil,Cervical Squamous Cell Carcinoma,T3b,NX,Not available,Mar-70,C53.9,C53.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,68.28,RNA,4C033A0C-8F98-46A1-820D-CDB648053615,Regional site,External,2011.0,Dead
s98,52F29745-0569-40A6-8470-4AF99887F4F1,UNCID_2137105.ce2ac3f1-b078-40ca-8894-56d323841e19.sorted_genome_alignments.bam,61,CE2AC3F1-B078-40CA-8894-56D323841E19,64d00705-5070-4338-9433-ba74424528b3,,Uterine Carcinosarcoma,Not available,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,E47933FA-634C-426E-9822-4B0E239B872C,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C55.9,C55,NO,NO,Complete Remission/Response,30.0,0.17,1.87,46.83,RNA,,,,,Alive
s10230,1F352063-9948-4E4D-AABD-A99C17FA0829,UNCID_1984170.bea8760d-cd7c-4d02-8032-cf32505fda56.sorted_genome_alignments.bam,74,BEA8760D-CD7C-4D02-8032-CF32505FDA56,9665b02f-970d-41fc-a07c-f01c8e3fe5a8,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,FE8D1A88-97EF-4ECE-BA4F-6A1A69C25EF3,Alive,Washington University - Cleveland Clinic,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1b,N0,Stage IA,Mar-70,C34.1,C34.1,NO,NO,Not available,45.0,0.16,,162.2,RNA,,,,2011.0,Alive
s10731,80C854C9-544B-47B8-834F-1BC7362E250D,UNCID_1898104.f5c78889-7c7f-4b88-8660-6560b49b7be4.sorted_genome_alignments.bam,75,F5C78889-7C7F-4B88-8660-6560B49B7BE4,4ad63dac-76a7-4527-abce-d7a0184e8739,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,81905199-81C6-4718-8BEA-951BC6C810A1,Alive,ABS - IUPUI,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1a,N0,Stage IA,Mar-40,C34.1,C34.1,NO,NO,Not available,34.0,0.15,,68.3,RNA,,,,2012.0,Alive
s17934,E7E1921B-2FAF-4611-AE09-25E3A94DF75B,TCGA-23-2078-01A-01R-1568-13_rnaseq.bam,66,9F35075D-4D81-44F2-A672-12028D6231BE,ebe677e6-94b6-45be-a58d-eaae4cf63d12,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,DC3D8CEA-908F-423F-976D-150BB1050063,Alive,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,136.0,0.15,1.8,342.0,RNA,,,,2001.0,Alive
s14013,46EB309A-5A78-4AC7-9AFB-302C8E840E82,G17228.TCGA-06-0649-01B-01R-1849-01.2.bam,73,ACB1160E-036A-4108-A9CE-D5F954191593,66f3c936-272e-4a1e-8567-f609af411329,64.0,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,09A0A6B2-8858-42ED-897F-7526097C24FE,Dead,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,,0.18,1.96,45.6,RNA,,,,2007.0,Dead
s9066,6951DD14-88B8-402C-B0CB-F68A01513EBE,UNCID_1197252.a054d780-7ac0-4c63-bcb7-4f2a8ea8a6f7.sorted_genome_alignments.bam,70,A054D780-7AC0-4C63-BCB7-4F2A8EA8A6F7,305eaef4-4644-46e3-a696-d2e4a972f691,166.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,228290F9-19F1-4B00-9765-C89DE4882E60,Dead,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.14,1.8,22.3,RNA,,,,2006.0,Dead
s5363,131C6578-CA34-4BC9-9C41-4F1CD827DB4E,UNCID_559578.941d70e7-2ac8-4809-baa4-7752df3c2ee3.110928_UNC6-RDR300211_00126_FC_6348UAAXX.4.trimmed.annotated.translated_to_genomic.bam,66,941D70E7-2AC8-4809-BAA4-7752DF3C2EE3,46a1fdb9-548d-44d1-ab77-d51d44ac8198,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,88F8998F-3D6A-4F9D-8B82-3250D26F5065,Alive,Washington University,University of North Carolina,United States,Mixed serous and endometrioid,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.16,1.95,84.68,RNA,,,,2008.0,Alive
s16655,A547D63F-67EA-4A9C-BD11-D8A4BFB9765A,UNCID_2619689.ece2a45a-7c07-44a2-baca-4a62aa38592f.sorted_genome_alignments.bam,66,ECE2A45A-7C07-44A2-BACA-4A62AA38592F,3da3cfec-5464-4dd8-9757-a0cdfe3536f8,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,BFA0E9B2-6A36-4865-9455-0A942DC9CA44,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,,Not available,30.0,0.17,1.87,99.67,RNA,,,,2008.0,Alive
s6165,E0944398-0739-4673-86D5-6667BE08AA47,UNCID_1137813.9a92e20a-2a43-4917-981d-c93179770050.sorted_genome_alignments.bam,52,9A92E20A-2A43-4917-981D-C93179770050,17f275c1-a0d4-487d-8f02-ea279584b4cd,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,0DCFD67B-64B2-4333-AF18-A2638DD82952,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T1c,N0,Stage IA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,2.04,56.3,RNA,,,,2010.0,Alive
s17399,092CA240-3687-4CA9-9020-55E2F8A7CFD6,TCGA-36-1575-01A-01R-1566-13_rnaseq.bam,83,A28EF775-C78B-416F-AFEB-89BA265440F0,6ea9877f-eb8d-4ee9-af4c-32a78474d9a6,,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,Not available,NCBI36_BCCAGSC_variant,Primary Tumor,E53C2985-F410-43F1-8FDE-7181112B9C14,Alive,BC Cancer Agency,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,120.0,0.14,1.8,348.0,RNA,,,,2006.0,Alive
s2796,124699F8-CA31-4862-8279-89B7DA21B6C1,UNCID_2235516.459468e0-79bc-4544-b168-27a85342d4c1.sorted_genome_alignments.bam,72,459468E0-79BC-4544-B168-27A85342D4C1,f632bc31-3aa0-4783-b10b-818ecb26d40b,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,248B4E29-74DE-40B8-B006-69C6BDAC640E,Alive,BLN - UT Southwestern Medical Center at Dallas,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4,N0,Stage III,Mar-20,C67.2,C67.2,NO,YES,Stable Disease,30.0,0.17,1.87,69.62,RNA,,,,2012.0,Alive
s13377,5B874CB8-BBEA-4250-9119-2CFAB36B6B3C,TCGA-AA-3672-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,90,21644D79-AE6D-4900-B2EB-E4E1BF31B0EE,c46971a1-cbac-425d-bac2-f4142c92522e,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG18,Primary Tumor,496316BA-00B4-49FF-9B67-02273FBFA945,Alive,Indivumed,Harvard Medical School,Germany,Colon Adenocarcinoma,T3,N1,Stage III,Mar-40,C18.4,C18.4,NO,,Not available,125.0,0.15,1.9,603.66,DNA,,,,2006.0,Alive
s2139,9F85795F-F9AB-4547-8D13-532176AEEF8C,TCGA-AG-3882-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,66,AB580F0B-74F6-4511-B62D-FBCD2E2AE01D,92c65e5a-3f07-49d9-ab69-46a0eb86ae88,,Rectum Adenocarcinoma,Not available,WGS,FEMALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG18,Primary Tumor,012ADC3A-0CEF-48E8-B468-7C816AFE1DE0,Alive,Indivumed,Harvard Medical School,Germany,Rectal Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.9,C18.9,NO,,Not available,118.0,0.15,1.9,926.0,DNA,,,,2008.0,Alive
s13854,9936DB46-79AF-4C46-95D9-5695A5BEADC9,UNCID_1783217.bec98631-8daf-4f90-a095-485b8078e4d6.sorted_genome_alignments.bam,68,BEC98631-8DAF-4F90-A095-485B8078E4D6,fa83dfb5-7386-4a35-9861-aa866478d5f1,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,1A058E77-7C20-4F50-AC89-185067EA7437,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Colon Adenocarcinoma,T4b,N0,Stage IIIB,Mar-40,C18.4,C18.4,NO,,Not available,41.0,0.14,1.8,101.8,RNA,,,,2010.0,Alive
s18148,89D2A2BE-9FFE-4DD2-BA3D-4225703CD965,TCGA-23-2081-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,49,4C8DD391-5A1C-490E-A7D7-FDE372C3EC47,41178cbc-db73-4007-b5d8-febebf7f578d,2342.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,48B84B42-0A80-4429-9D6F-1A51B8AAAE2E,Dead,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,124.0,0.17,1.8,514.0,RNA,,,,2000.0,Dead
s10852,4F0967C9-E1CD-4EBA-B4A2-0B21F3E2A3DF,UNCID_1366131.2cb8a95d-20c3-4623-9b4d-b06b2a494b18.sorted_genome_alignments.bam,76,2CB8A95D-20C3-4623-9B4D-B06B2A494B18,ef03654a-dcf1-41ff-a67e-4f3fbf9ba807,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,7E1638D3-F134-4DC8-BECC-9F4D49D83024,Alive,Washington University - St. Louis,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T1a,N0,Stage IA,Mar-55,C34.1,C34.1,NO,,Not available,40.0,0.13,,13.2,RNA,,,,2011.0,Alive
s9545,7A9C81B1-91C0-4379-A0A1-2FAF690C9254,UNCID_399985.d0100b1d-9fa8-46b6-94f0-af3f9e747972.110712_UNC12-SN629_0108_AC0402ABXX.2.trimmed.annotated.translated_to_genomic.bam,64,D0100B1D-9FA8-46B6-94F0-AF3F9E747972,73c712fe-54d6-4743-90bb-03313eb9fa77,139.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,DF548CB7-7766-47E9-AAFA-D8EC610AB3DB,Dead,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.15,1.6,63.63,RNA,,,,2004.0,Dead
s12901,1371B8D3-BD61-41EE-9272-6F1CD73DBA7D,UNCID_1592785.f45cca58-c48d-4152-bb36-7e5ee0fe2f89.sorted_genome_alignments.bam,58,F45CCA58-C48D-4152-BB36-7E5EE0FE2F89,10994156-7c2f-420e-aeb8-11d566b3d5e4,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,F3DB9B58-D60D-41F7-A3D7-6F713272EFB5,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N1,Stage III,Mar-40,C18.9,C18.9,NO,,Not available,150.0,0.15,1.8,463.3,RNA,,,,2007.0,Alive
s10714,0CB2AC98-511E-4CAA-AAB0-50A69A8C15F4,UNCID_1229046.f338175a-fa1e-4b98-91e2-f4f0ee349e8e.sorted_genome_alignments.bam,77,F338175A-FA1E-4B98-91E2-F4F0EE349E8E,c6d78e27-e510-4f57-abae-19efa6105a8d,1081.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,7CA68089-C61F-4D31-8CC8-FB11AE70910A,Dead,Johns Hopkins,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T3,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,,Not available,110.0,0.15,1.8,74.3,RNA,,,,1995.0,Dead
s220,DB951476-E1A5-4731-8C40-DBE710922B60,TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.bam,45,8CDB01C8-C2D9-40DB-84EE-00B50B9EC314,367869f9-bbe7-4e57-a16f-f2b63f2de697,,Uveal Melanoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-UVM,Illumina HiSeq,Eye,WHITE,HG19_Broad_variant,Primary Tumor,F1A146CE-B2C6-4CD5-9153-F640D38ABAF1,Alive,Institut Curie,MD Anderson - Institute for Applied Cancer Science,France,Not available,T3b,N0,Stage IIIA,Mar-72,C69.4,C69.40,NO,NO,Not available,30.0,0.17,,53.75,DNA,,,,,Alive
s4292,F7790260-8A73-4F8A-B930-0DAC5DEF74C8,UNCID_1626279.abe099ed-caea-4903-aa4a-2729d2b28da2.sorted_genome_alignments.bam,73,ABE099ED-CAEA-4903-AA4A-2729D2B28DA2,e70465f6-1922-4eb7-b646-8b01ad3ce77b,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,58FC1E66-39C4-44D1-BDD3-338E0D833792,Alive,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,20.0,0.15,1.83,25.0,RNA,,,,2008.0,Alive
s10252,C923EEAA-1B36-49B3-97B7-F64875389D5F,G47088.TCGA-68-8250-01A-11D-2293-08.1.bam,66,71A2B4A2-88DD-4911-A67E-70B3309C4A12,7b982d5e-3a7d-40ac-bd25-6044c62879b6,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,A6A1A05E-9126-45CD-B7BE-C1C342FAF5AF,Alive,Washington University - Cleveland Clinic,Broad Institute of MIT and Harvard,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1a,N0,Stage IA,Mar-70,C34.1,C34.1,NO,NO,Not available,38.0,0.05,,242.3,DNA,,,,2011.0,Alive
s9122,957D9180-D386-435C-B48B-8922B2CF6C50,UNCID_396759.cc81a899-9b05-4804-b180-f33f885f3908.110812_UNC16-SN851_0075_BD0DE5ABXX.1.trimmed.annotated.translated_to_genomic.bam,63,CC81A899-9B05-4804-B180-F33F885F3908,74749fe8-f5d0-4d0d-8c7a-e56eba6503b3,561.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,D6A730EF-3F0D-47C1-977E-5C80647356D4,Dead,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,NX,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.8,93.8,RNA,B55530D4-56D0-4256-90F8-0AAF14040FF3,Distant Recurrence,OTHER: SPECIFY IN NOTES,2006.0,Dead
s4875,BF004BA1-3DE0-4088-91EB-38CCBF23FD49,UNCID_1972610.8025c2b5-a137-4c88-9ac4-cc4be43e4f25.sorted_genome_alignments.bam,58,8025C2B5-A137-4C88-9AC4-CC4BE43E4F25,0878e44d-bdc8-4d5f-9bf4-31101f14f797,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,47BF70A1-6738-495F-9E61-92FEAF33C28C,Alive,University Health Network,University of North Carolina,Canada,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,20.0,0.16,1.84,26.32,RNA,,,,2011.0,Alive
s16692,12FE9713-9BDA-4178-8A6B-4E1C99E502DD,UNCID_1183155.bb931f9d-802e-4e02-b503-a637aa369e8b.sorted_genome_alignments.bam,72,BB931F9D-802E-4E02-B503-A637AA369E8B,68015cc7-d3a1-4c90-b8fb-5d14143d9960,,Liver Hepatocellular Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,Not available,HG19,Primary Tumor,FEE48A64-CF2F-4AE9-B3CF-315410D8E8AE,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,,Not available,30.0,0.17,1.86,67.72,RNA,,,,2001.0,Alive
s15523,D2264558-E25D-4169-9E22-8F3C23B50AD9,TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam,78,A78CD28C-EDAF-4439-905B-44B4616DF078,c3b2c38d-81a3-42fd-a41e-6f6de3934007,14.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,7BE274D5-D5A0-4EF9-A65A-4127ED864F0C,Dead,MD Anderson Cancer Center,MD Anderson - Institute for Applied Cancer Science,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2b,Stage IVA,Mar-70,C14.8,C14.8,NO,,Not available,37.0,0.16,,79.73,DNA,,,,1995.0,Dead
s11186,5F37313C-33B4-4955-AC9F-61AE5273A4A1,UNCID_1905230.a0e0a895-ce81-44a6-a21e-453e727acdbb.sorted_genome_alignments.bam,77,A0E0A895-CE81-44A6-A21E-453E727ACDBB,a905d275-9283-4fa6-bbbf-46019bd1bcb7,,Lung Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,E3AB8511-D37D-4CEC-A954-CFC616B2CEFD,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Adenocarcinoma Mixed Subtype,T1,N0,Stage IA,Mar-55,C34.3,C34.3,NO,,Complete Remission/Response,44.0,0.14,,132.2,RNA,,,,2003.0,Alive
s11088,1EACC7BA-8F18-47A4-9D5E-39E61042C1D6,UNCID_2116077.cc85d7b0-8421-4ea1-b647-92d3d0bbe550.sorted_genome_alignments.bam,73,CC85D7B0-8421-4EA1-B647-92D3D0BBE550,e00a60d7-4253-443d-a187-680ad0931349,1653.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,9F9BD43E-2204-4837-A4A1-8BBA437B179B,Dead,Thoraxklinik at University Hospital Heidelberg,University of North Carolina,Germany,Lung Papillary Adenocarcinoma,T2,N0,Stage IB,Mar-60,C34.1,C34.1,NO,YES,Complete Remission/Response,30.0,0.16,1.84,20.63,RNA,,,,2007.0,Dead
s3718,74A72790-17B8-4B97-B376-A882A983465D,UNCID_2394054.6d249571-1535-4db3-9860-a56a02941200.sorted_genome_alignments.bam,55,6D249571-1535-4DB3-9860-A56A02941200,4434864a-8a0d-488e-b9a7-6749719663e5,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,CBC53357-B90E-459C-AD5D-B9457084E2E7,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.18,1.84,40.99,RNA,,,,2009.0,Alive
s14848,F577AA24-2981-4D0A-BE85-3A765128D615,TCGA-MX-A666-01A-11R-A31P-31_rnaseq.bam,61,5E36DAD4-D46C-44CA-B5A4-93170789C165,d04e2e8c-9d58-4514-8ab7-3642289d4de0,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,D6F47BDE-5A0E-4916-88E4-14BEE04AB6A3,Alive,MSKCC,Canada's Michael Smith Genome Sciences Centre,United States,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T2,NX,Stage IIA,Mar-40,C16.9,C16.9,NO,NO,Not available,30.0,0.18,1.85,25.9,RNA,,,,2013.0,Alive
s10513,18F84919-2C26-4506-86F6-203C0E520821,UNCID_1033843.aa7c9175-113a-4a7b-8577-18478b0fffd3.sorted_genome_alignments.bam,56,AA7C9175-113A-4A7B-8577-18478B0FFFD3,ee850103-6314-41a3-9734-8b520de95b40,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,48F646FE-03C6-4E7B-ACF1-9869E379443E,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.3,C34.3,NO,,Not available,39.0,0.16,1.7,54.2,RNA,FDCE6147-F6D3-4DFE-B769-702A980A83D0,Primary Tumor Field,EXTERNAL BEAM,2002.0,Alive
s869,E6CE722D-EE40-40A2-B359-D560A287DC52,UNCID_2539120.f3b11290-409e-442e-acd8-a68a3e52fe24.sorted_genome_alignments.bam,60,F3B11290-409E-442E-ACD8-A68A3E52FE24,c53d66d9-ad9a-417e-a441-df5bcf1ae13f,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,A3DE4634-8ACB-47DE-8986-1478626464BC,Alive,St. Joseph's Hospital (AZ),University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T2,N0,Stage IB,Mar-00,C25.0,C25.0,NO,NO,Complete Remission/Response,10.0,0.15,1.85,6.55,RNA,,,,2013.0,Alive
s16917,447F2B90-42A8-499B-B542-EB57B8188A98,UNCID_2247747.a76c84d3-7243-465b-bbfe-087dbfba4b24.sorted_genome_alignments.bam,54,A76C84D3-7243-465B-BBFE-087DBFBA4B24,76cc9c06-0827-465e-bab3-5f4115295ebe,,Liver Hepatocellular Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,Not available,HG19,Primary Tumor,2953EEFA-B97D-4328-90E1-5F991E2C2713,Alive,Saint Mary's Health Care,University of North Carolina,United States,Hepatocellular Carcinoma,T1,NX,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.18,1.84,77.89,RNA,,,,2013.0,Alive
s15205,8D0ADB42-AAC5-4FDA-AA22-29072803C23B,TCGA-HU-A4GQ-01A-11R-A36D-31_rnaseq.bam,71,99CE4992-5A64-46FE-9B36-DBFEAEAEAD17,7739f659-0e25-4404-ad25-ee52fbbcfd44,3.0,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,22EC17AB-22FC-4E78-A559-EBC9493140E6,Dead,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Intestinal Adenocarcinoma  Tubular Type,T4b,N2,Stage IIIC,Mar-11,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.18,1.77,35.16,RNA,,,,2011.0,Dead
s3575,61E80F9C-0045-4EB0-A1FB-C36813BDD99D,UNCID_2621310.a79de49e-9b1c-4512-b6ed-df4a858c4875.sorted_genome_alignments.bam,72,A79DE49E-9B1C-4512-B6ED-DF4A858C4875,9357e8eb-1ce5-4c0f-a668-e5e7f3031d6c,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,BFBE6BF9-86C3-41DB-9081-8832E8CBC059,Alive,University Medical Center Hamburg-Eppendorf,University of North Carolina,Germany,Prostate Adenocarcinoma Acinar Type,T3a,N1,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.16,1.82,24.89,RNA,,,,2013.0,Alive
s1720,AD047AFB-888A-4EC0-B30B-D5CF46F89400,TCGA-2H-A9GM-01A-11R-A37I-31_rnaseq.bam,53,7B4FE474-B28B-466B-9985-8C34EF90FCCF,6584fa8f-b4f4-4844-a71e-3bfb731ad445,424.0,Esophageal Carcinoma,Not available,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,Not available,GRCh37-lite,Primary Tumor,DDE76185-E46B-4E63-9072-14322CEFAA57,Dead,Erasmus MC,Canada's Michael Smith Genome Sciences Centre,Netherlands,Not available,T1,N1,Stage IIB,Mar-40,C15.5,C15.5,NO,YES,Not available,30.0,0.16,1.88,46.36,RNA,,,,,Dead
s8289,97C2AB46-F825-497E-B23D-CC152C5C6887,UNCID_2348238.2a73d13f-1bbb-4591-9524-181d9539d3ae.sorted_genome_alignments.bam,28,2A73D13F-1BBB-4591-9524-181D9539D3AE,b7395082-415b-4ab3-bf1e-59d0f4e4b488,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,552094AB-C348-478B-8E43-9E9ECDB6F38E,Alive,Dept of Neurosurgery at University of Heidelberg,University of North Carolina,Germany,Astrocytoma,Not available,Not available,Not available,Mar-00,C71.0,C71.0,NO,YES,Partial Remission/Response,30.0,0.15,1.89,13.55,RNA,,,,2006.0,Alive
s8286,0E9F9582-5A9D-49E6-9716-E970BBD7A844,UNCID_2334671.2ad4f620-2c9a-4bc0-a24d-fddfee88ba32.sorted_genome_alignments.bam,25,2AD4F620-2C9A-4BC0-A24D-FDDFEE88BA32,df78e63d-4387-4177-b24f-f0e2c6c7ac32,,Brain Lower Grade Glioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,7DFF820B-E472-4F13-A56A-F6D1976E60B3,Alive,University of Sao Paulo,University of North Carolina,Brazil,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,NO,Stable Disease,30.0,0.16,1.9,17.09,RNA,,,,2011.0,Alive
s12925,07EF2494-1183-4250-A875-0EC35D4708AB,UNCID_1722274.15907695-4f7d-4e7c-a4d3-ca016c72ebba.sorted_genome_alignments.bam,67,15907695-4F7D-4E7C-A4D3-CA016C72EBBA,e3b6018c-ab2c-47c5-b183-a295d0110835,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,7E5E20F6-5276-4CBA-A73F-1580DF93AA58,Alive,University of Michigan,University of North Carolina,,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.0,C18.0,NO,,Not available,30.0,0.17,1.86,49.52,RNA,,,,2000.0,Alive
s9050,F03E5FC3-12E1-4DA5-B79A-B380E4B31CD7,UNCID_1188498.c71a4961-b4a0-4736-b986-8c95e86f1876.sorted_genome_alignments.bam,57,C71A4961-B4A0-4736-B986-8C95E86F1876,e002c248-0db9-4f94-8590-88dfd6c0c642,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,2EC161E4-9607-42BE-B23F-3F640BB38E04,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2b,N0,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,40.0,0.15,1.8,142.3,RNA,,,,2004.0,Alive
s10264,14782B4A-03CB-43FA-BEAA-398AAD876CA1,UNCID_1034217.790c2e10-c79a-412d-9a24-d571652ff80e.sorted_genome_alignments.bam,73,790C2E10-C79A-412D-9A24-D571652FF80E,469eba45-5046-4d8a-9f9a-dfbd1e7cf560,1154.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,D82D97D1-35BB-4FBC-9A54-DBA553393F21,Dead,Roswell Park,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.1,C34.1,NO,,Not available,40.0,0.13,,126.2,RNA,9444E04B-8BD2-4A3E-902B-E794DA2609A7,Not available,Not available,2003.0,Dead
s4187,9A800CF6-0A45-45AE-8034-3B53020FA420,UNCID_1535336.c3841b03-197a-4cd1-9331-02fde85bcb55.sorted_genome_alignments.bam,52,C3841B03-197A-4CD1-9331-02FDE85BCB55,cf70909e-5143-47ae-b8ca-c3ae6ace7be2,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,74A8D844-92DB-4829-B687-A54A41C32F36,Alive,Roswell Park,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3a,N1,Not available,Mar-50,C61.9,C61,NO,NO,Not available,27.0,0.16,,82.2,RNA,,,,2010.0,Alive
s11923,67979658-3BB3-476F-AF44-5CA0C09BE650,UNCID_2194464.5837b10d-8c02-4d07-9763-8a4f32e294fc.sorted_genome_alignments.bam,61,5837B10D-8C02-4D07-9763-8A4F32E294FC,2b7c7e88-a204-44a4-ab28-624b586dc238,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,72F38FDA-4065-49C4-A1B8-F0E8F3473980,Alive,International Genomics Consortium,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1b,NX,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.15,1.87,55.13,RNA,,,,2012.0,Alive
s6825,230A5F97-ECD5-4466-B709-9922DEA51395,UNCID_1139981.9f440cd6-d55f-4cb6-a433-637ef1f9d38f.sorted_genome_alignments.bam,74,9F440CD6-D55F-4CB6-A433-637EF1F9D38F,ccb22ecc-6e18-44b8-ad48-6ab51314b16e,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,530315DE-D048-40F6-B0CC-3C7FB9875E46,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T3,N0,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,2.02,46.3,RNA,,,,2010.0,Alive
s10401,FECC74FE-5956-4D34-ABB4-1EE45CAC4EED,UNCID_1066312.d3642776-8fd7-4cdd-b94a-1d558b5ac69d.sorted_genome_alignments.bam,73,D3642776-8FD7-4CDD-B94A-1D558B5AC69D,e7d1b042-5b1c-4c29-b501-a5ef4810ecd2,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,49395D22-CD07-4AB7-BDF3-CFA56687BA43,Alive,University of Pittsburgh,University of North Carolina,United States,Lung Basaloid Squamous Cell Carcinoma,T2,N1,Stage IIB,Mar-83,C34.1,C34.1,NO,,Not available,125.0,0.17,1.8,118.3,RNA,,,,2009.0,Alive
s2364,D84DBA8F-850B-49CE-989C-D64E0BFE13DE,UNCID_2419958.4d849e0c-3c5c-4729-963d-595f1b69170a.sorted_genome_alignments.bam,57,4D849E0C-3C5C-4729-963D-595F1B69170A,7fb69277-2aff-45e0-8f44-d2794f831a2a,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E452E671-C60D-4042-A06F-D7EE0BE0234E,Alive,BLN - Baylor,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C48.0,C48.0,NO,NO,Not available,30.0,0.16,1.88,13.04,RNA,,,,,Alive
s13775,8A53C466-5E08-435F-B809-D910FBE9A7C4,UNCID_1965787.1eee1136-f567-482b-b64d-a4761e615170.sorted_genome_alignments.bam,66,1EEE1136-F567-482B-B64D-A4761E615170,39b6ae01-c97b-4234-8a28-208fdf170432,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,CB16E564-E613-4F02-9F74-E807A51DD512,Alive,Christiana Healthcare,University of North Carolina,United States,Colon Adenocarcinoma,T3,N1b,Stage IIIB,Mar-40,C18.2,C18.2,NO,,Not available,32.0,0.14,1.7,42.2,RNA,,,,2010.0,Alive
s8763,14EE801F-08B4-4014-9C68-D24278B4CB28,UNCID_1372685.5a559e30-17cb-4467-b54c-18dcfdb93fde.sorted_genome_alignments.bam,34,5A559E30-17CB-4467-B54C-18DCFDB93FDE,92a7c445-2217-400a-bdcd-df41502416b6,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,C68FC12C-C538-4A89-9F6E-C0800A5A6B53,Alive,Henry Ford Hospital,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.9,C71.9,NO,,Not available,39.0,0.15,1.8,195.8,RNA,DA1371F1-7CE0-417E-914C-6FDA8A4FCE52,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s257,8388DF36-E4C1-4450-BC87-ACC118CE705E,TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.bam,78,07397855-A0D5-4287-A21B-5AB83A4E0DE0,64422cc5-5e5b-4ef9-a9e2-214cebf8dfbc,,Uveal Melanoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UVM,Illumina HiSeq,Eye,WHITE,HG19_Broad_variant,Primary Tumor,44AD0268-6B48-4264-A1DD-58C2302224D7,Alive,Institut Curie,MD Anderson - Institute for Applied Cancer Science,France,Not available,T3a,N0,Stage IIB,Mar-70,C69.3,C69.30,NO,NO,Not available,20.0,0.16,,49.86,DNA,,,,,Alive
s723,EBD2BA7E-1AA3-4666-B39D-C59157E0A310,UNCID_2616666.f7a4adf3-31b2-43d8-80ca-889aedfd0152.sorted_genome_alignments.bam,26,F7A4ADF3-31B2-43D8-80CA-889AEDFD0152,21e8b3c8-0be7-4fb1-b986-9e5403d04e26,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,WHITE,HG19,Primary Tumor,B9C70F51-10E9-4A19-BF6E-11CA834FDD14,Alive,University of North Carolina,University of North Carolina,United States,Not available,T1,NX,Not available,Mar-85,C62.9,C62.90,NO,NO,Not available,30.0,0.15,1.79,43.95,RNA,,,,,Alive
s11033,4EE741D6-F908-4696-8D08-799FDD357CAC,UNCID_1111565.ebbb3b0d-c092-4af4-919a-25fcb49eac69.sorted_genome_alignments.bam,42,EBBB3B0D-C092-4AF4-919A-25FCB49EAC69,e1c55bac-bb41-4964-add5-ecd6ba04b58d,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,180EB213-0DDC-4F10-AB0E-B3AF92CDE3C3,Alive,University of Pittsburgh,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,,Not available,29.0,0.15,1.8,111.2,RNA,47FFDBD3-4E1B-4E78-B229-1E3CF0B787D6,Primary Tumor Field,EXTERNAL BEAM,2007.0,Alive
s25,0E518E80-3774-4AC0-B5CE-30F50E46F059,UNCID_2560841.f7f581cf-3c93-4eaf-9f10-299006f058ce.sorted_genome_alignments.bam,69,F7F581CF-3C93-4EAF-9F10-299006F058CE,9d9109f5-5917-4126-8e34-8a7e4632e913,,Cholangiocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-CHOL,Illumina HiSeq,Bile Duct,WHITE,HG19,Primary Tumor,C333B64D-64B7-448F-A786-EE7B82B84B06,Alive,University of North Carolina,University of North Carolina,United States,Not available,T3,N1,Stage IVB,Mar-60,C22.1,C22.1,NO,YES,Not available,30.0,0.17,1.85,19.82,RNA,,,,,Alive
s4834,E0B39944-9215-41F2-ACDC-1CB7F9CFA552,UNCID_1614801.6eefe77a-d312-44fc-9b9e-7c3b439a7e23.sorted_genome_alignments.bam,77,6EEFE77A-D312-44FC-9B9E-7C3B439A7E23,a98bbe29-8817-4380-a738-3c1bf9f8e0cc,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,E113E0F0-3AE5-48A3-A226-AD920F41259E,Alive,Mayo Clinic,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.89,90.6,RNA,,,,2010.0,Alive
s17560,82AA0249-C9BA-4E7D-AD24-3778496E08F9,TCGA-13-0923-01A-01R-1564-13_rnaseq.bam,74,B75DE387-11AE-4D46-81A1-54D15ECAE42A,378f7ea2-86b4-4072-80b8-e12d67193106,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,38E5FC32-615E-435D-AE6E-B79701ABA593,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,,0.15,1.7,391.0,RNA,,,,2008.0,Alive
s13240,EC7040DC-ACCF-418D-8B16-B296F5838A4D,UNCID_1597176.aee9c56c-b7fc-4fa1-9c77-08087dbe0169.sorted_genome_alignments.bam,81,AEE9C56C-B7FC-4FA1-9C77-08087DBE0169,c5c4a0a5-900d-483d-9282-475654d63265,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,BC08B757-ED0A-44C0-88CD-85496BB72A75,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.0,C18.0,NO,,Not available,109.0,0.15,1.8,648.3,RNA,,,,2007.0,Alive
s2801,80BD303D-1402-4F9D-8266-C89F617DFFF9,UNCID_2306102.fa74ebb2-007d-407a-ba07-12976b75056d.sorted_genome_alignments.bam,87,FA74EBB2-007D-407A-BA07-12976B75056D,6a1eee8d-cf62-47e9-9322-c18633cb3ee9,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,E70BF0B1-0E0E-4484-93F2-E312AA575F98,Alive,BLN - UT Southwestern Medical Center at Dallas,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4a,N2,Stage IV,Mar-20,C67.9,C67.9,NO,NO,Progressive Disease,30.0,0.17,1.92,49.22,RNA,,,,2012.0,Alive
s5422,C5EB85EE-9D0B-4544-8CFD-D5EB04E0499D,UNCID_1622088.ec3e03af-251e-497f-8cb4-b05816df2e12.sorted_genome_alignments.bam,57,EC3E03AF-251E-497F-8CB4-B05816DF2E12,32e33897-29c8-48f2-b833-98f37204e0e7,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,853196B6-8C1D-462F-AF8F-ACF2551F633D,Alive,Cedars Sinai,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.81,52.68,RNA,,,,2004.0,Alive
s6837,BFED4282-58BA-407D-BBB3-C9C5677D7050,UNCID_1147139.d99fef01-1eb5-4300-8031-d5a157fd5b28.sorted_genome_alignments.bam,71,D99FEF01-1EB5-4300-8031-D5A157FD5B28,0b172e29-6166-4863-803d-a0a010887c11,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,EDF2DBBE-B055-4D90-BC41-72355621B99E,Alive,Duke,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T4,N1a,Stage IIIB,Mar-00,C50.9,C50.9,NO,,Not available,10.0,0.15,1.92,14.31,RNA,,,,1993.0,Alive
s8228,24604572-3498-498F-BA90-35F23DEAF8F6,UNCID_2045421.f23834b0-13c3-4dd5-a20b-0f20cd92ec23.sorted_genome_alignments.bam,51,F23834B0-13C3-4DD5-A20B-0F20CD92EC23,4bd8ebc1-6f6e-44a2-8544-106901a7bae5,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,90E762B7-DEC2-4570-961C-F19C6C0AE693,Alive,Henry Ford Hospital,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,NO,Not available,30.0,0.17,1.82,20.43,RNA,EB5F5C6D-E53B-43E7-9B8C-27E70CD579F7,Primary Tumor Field,External,2012.0,Alive
s4303,7CE44BC0-1E3A-4270-9B1E-DD81065C1304,UNCID_1636385.bbc76639-b9f4-4e9f-afa2-e319eee91b48.sorted_genome_alignments.bam,50,BBC76639-B9F4-4E9F-AFA2-E319EEE91B48,61935424-44d0-4211-81c1-c925e436eac5,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,95F418CE-FCD9-4402-BC24-1520F45CB6B7,Alive,Duke,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-20,C54.1,C54.1,NO,,Not available,30.0,0.15,1.6,87.68,RNA,,,,2008.0,Alive
s14590,9368EA2F-1289-4BA1-938B-03FB0267C88B,_1_TCGA-CG-4462-01A-01R-1157-13_rnaseq.bam,72,03ECE93C-67F7-42B9-942F-653583CA3BEE,e9ea3687-0db3-47f3-8099-b4fc054397f1,0.0,Stomach Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-STAD,Illumina GA,Stomach,Not available,GRCh37-lite,Primary Tumor,D4F28131-D917-449B-95DC-DC6BA2EEE81B,Dead,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Adenocarcinoma  Diffuse Type,T3,N3,Stage IV,Mar-45,C16.9,C16.9,NO,,Not available,29.0,0.17,1.6,26.3,RNA,,,,2008.0,Dead
s10145,A5471222-7450-4D5B-B07A-5E599F4D5899,UNCID_2078840.42700ab7-f1fe-41de-97b0-3fba56091b82.sorted_genome_alignments.bam,54,42700AB7-F1FE-41DE-97B0-3FBA56091B82,9f247eef-9c0a-4e7a-a2e8-2a84225ba307,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,1ACE1FCC-1CE6-4D31-9E7F-7AA9F155EE78,Alive,University of Minnesota,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-71,C34.1,C34.1,NO,NO,Not available,30.0,0.17,1.81,32.26,RNA,BD7F96C4-91F6-4508-A71F-F20F8172C3D0,Regional site,External,2012.0,Alive
s10374,3589B00A-196A-4D1C-A36D-09ACA8901B8E,UNCID_1033396.7828187d-3fbc-4139-8546-c6d92fef3e0f.sorted_genome_alignments.bam,45,7828187D-3FBC-4139-8546-C6D92FEF3E0F,86b165c2-d0e6-4a4f-84ed-aa95e3133627,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,D254D457-F42F-42A1-88FF-1E05158C554E,Alive,Washington University - St. Louis,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2a,N1,Stage IIA,Mar-70,C34.1,C34.1,NO,,Not available,39.0,0.14,,132.2,RNA,,,,2011.0,Alive
s15343,5DE81B16-1E49-4ED5-BFB0-A9224C82954B,TCGA-VQ-AA64-01A-11R-A414-31_rnaseq.bam,68,3EACCE4E-0232-47B0-9181-9B84C19B5EE4,fb143117-c3ad-4f4b-8f39-7586279e8eaa,560.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,390B76DC-0F3B-4443-8E29-C97BE5D56181,Dead,Barretos Cancer Hospital,Canada's Michael Smith Genome Sciences Centre,Brazil,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T3,N2,Stage IIIB,Mar-44,C16.0,C16.0,NO,,Not available,30.0,0.17,1.87,43.43,RNA,7621DA74-35BF-4444-BC39-A798134D4B53,Primary Tumor Field,External,2011.0,Dead
s1449,F7906719-FBFC-4B67-93E9-6FB7E99501DC,UNCID_2324650.41a6b734-2741-4d93-8813-ed27b21c81c0.sorted_genome_alignments.bam,45,41A6B734-2741-4D93-8813-ED27B21C81C0,da30a845-c4d3-4c78-b8b0-210239224f8f,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,48ECAB30-CF47-43A8-AF5C-026140A53EF8,Alive,Medical College of Wisconsin,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,Not available,Not available,Not available,Mar-70,C53.9,C53.9,NO,NO,Not available,20.0,0.17,1.8,38.21,RNA,3C5402B7-9A6A-493C-B61C-1C408C3C2CA8,Regional site,External,2001.0,Alive
s16108,AEC32216-0015-43CA-A460-F73640FD7250,UNCID_1497626.b8c98129-fc39-4a2f-966e-041474135925.sorted_genome_alignments.bam,63,B8C98129-FC39-4A2F-966E-041474135925,34227de4-d23c-46d6-b78b-49add24a4b88,521.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,24A2DD45-0453-4BFA-AF4C-CDE8CB0C0CFB,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2c,Stage IVA,Mar-70,C32.9,C32.9,NO,,Not available,29.0,0.15,,211.2,RNA,,,,2001.0,Dead
s16566,988FD0C5-C91D-4A8A-AF6A-11382DA4DC0D,UNCID_1728576.ec85470e-1f9c-46fd-87d2-02b00947abb5.sorted_genome_alignments.bam,44,EC85470E-1F9C-46FD-87D2-02B00947ABB5,222a2e5b-9d55-4477-8a54-7776bd44f8a7,,Kidney Chromophobe,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,C19F21CB-4036-4CC2-9AD5-B805CA7F873C,Alive,Harvard,University of North Carolina,United States,Kidney Chromophobe,T1b,N0,Stage I,Mar-17,C64.9,C64.9,NO,NO,Complete Remission/Response,30.0,0.15,,109.2,RNA,,,,2005.0,Alive
s544,7F84A775-44E6-48E8-AA0E-AB33AE076E56,UNCID_2589144.447dfa38-6fe8-4e36-8eaa-8c9e7523d058.sorted_genome_alignments.bam,64,447DFA38-6FE8-4E36-8EAA-8C9E7523D058,2f6f86f3-6d31-4a8c-b70d-2759b44bac6c,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,83AA5979-8A5F-4759-A439-3F864284BF96,Alive,Thoraxklinik,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-81,C38.1,C38.1,NO,NO,Not available,30.0,0.17,1.96,44.2,RNA,5F981F0C-438E-4AC5-B461-9AF177327307,Primary Tumor Field,External,,Alive
s8780,F87B5C04-3815-4EF0-B147-7DD243BC3E74,UNCID_1648526.80dac2db-4e32-4854-ba10-2d9aa059bf45.sorted_genome_alignments.bam,37,80DAC2DB-4E32-4854-BA10-2D9AA059BF45,48314732-5d1c-43e6-9878-5b58dfaeb06a,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,4A579925-CCA7-4212-9299-843BB6EB0EB7,Alive,Case Western - St Joes,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.9,C71.9,NO,,Not available,37.0,0.16,,45.2,RNA,,,,2010.0,Alive
s9559,D3B80677-63A6-47FD-91C0-3A9A7418CA6A,UNCID_610896.dd88d1bb-37a6-4b6b-b0bb-e637452ea133.111025_UNC9-SN296_0252_AD0F59ABXX.6.trimmed.annotated.translated_to_genomic.bam,51,DD88D1BB-37A6-4B6B-B0BB-E637452EA133,ea26d89f-2843-489b-8627-3d5ed0cabc2a,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,A568933F-CB58-4988-918D-FE963F982C47,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.15,1.7,118.8,RNA,,,,2005.0,Alive
s3598,00039222-B24D-4C86-B6AC-FFC00B3B6ECE,TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.bam,59,0A4FA030-2417-4F6F-8B86-5036FCA48F1E,6755c231-355f-4cc3-85f1-6306c7f5d44b,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,D0873929-EAC8-42E2-AF6F-DF3CB9CE698C,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,35.0,0.14,1.9,253.7,DNA,,,,2009.0,Alive
s8171,E56B76D5-3AEE-42ED-95E8-7F83B0064A79,UNCID_1509215.8f248b27-4433-493d-87d7-e9e174317470.sorted_genome_alignments.bam,62,8F248B27-4433-493D-87D7-E9E174317470,a6ee311c-0a7b-4f47-86f1-f2164b128f9c,1762.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,DED0F767-9CEE-4F1D-8E91-CB242D30B57E,Dead,Duke,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.9,C71.9,NO,,Not available,38.0,0.15,1.8,13.2,RNA,,,,2000.0,Dead
s3573,366B6163-10B4-4A43-92F5-4758DD6AA126,UNCID_2615450.4e640b86-66f7-458c-af5c-b195778aa295.sorted_genome_alignments.bam,61,4E640B86-66F7-458C-AF5C-B195778AA295,743ffc51-d613-407f-b040-e99969c31802,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,72735209-5DA0-4EA3-9D81-A4F7200899B7,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,20.0,0.16,0.82,13.09,RNA,,,,2013.0,Alive
s2230,234C4F0A-1ACC-4F50-904B-5B0A674A2D85,UNCID_1860498.cf841dab-ef32-4a52-9040-2b02dfca1d0f.sorted_genome_alignments.bam,66,CF841DAB-EF32-4A52-9040-2B02DFCA1D0F,a2b6246d-2b80-49c5-968b-694b4e8171dc,,Rectum Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-READ,Illumina HiSeq,Colorectal,Not available,HG19,Primary Tumor,07505F47-745B-40C9-8994-1A12582E4342,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C19.9,C19,NO,,Not available,139.0,0.15,1.8,450.0,RNA,F8AD5111-4DB0-47DE-9147-176C61D00915,Primary Tumor Field,External,2007.0,Alive
s11619,29FC53DA-B568-44B2-9C40-0F1B1EBCD69B,UNCID_2214763.6d63f739-c10c-4d38-b7d8-fd40aa5c4b6f.sorted_genome_alignments.bam,65,6D63F739-C10C-4D38-B7D8-FD40AA5C4B6F,f8ac66a2-16a5-4230-986b-1da8d0a61361,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,3FA99B5C-56DF-40E4-A993-0B7EC3165E2B,Alive,International Genomics Consortium,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T2a,NX,Stage II,Mar-60,C64.9,C64.1,NO,NO,Not available,30.0,0.16,1.84,40.16,RNA,,,,2012.0,Alive
s16728,230BA89C-4EAC-4F8F-8516-A5FBD58A8119,UNCID_2232147.4ed5467c-be43-4125-a6c4-7b7aad6ea5f6.sorted_genome_alignments.bam,72,4ED5467C-BE43-4125-A6C4-7B7AAD6EA5F6,5449c232-56f1-4e03-9421-aba3ae180107,283.0,Liver Hepatocellular Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,7A4F8926-1472-4A9B-B0F6-E28BD7CEB6E8,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,YES,Not available,30.0,0.17,1.88,70.22,RNA,,,,2012.0,Dead
s9874,9CA921AF-B91A-46F6-834E-9C0DBAA0D972,UNCID_368210.TCGA-BP-4758-01A-01R-1289-07.110429_SN851_0036_BB0BGLABXX.6.trimmed.annotated.translated_to_genomic.bam,40,E7421840-5E51-4BB8-AEFE-2843171B5BD0,44143697-c4b3-4051-9594-d53131c05889,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,C2145112-A7AC-45C3-A50D-7A644D44C00F,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,3.0,0.14,1.8,69.3,RNA,,,,2004.0,Alive
s12302,C2EC817B-1C75-4D88-91A9-30FFAACEEDF9,UNCID_1652767.83D04848-BB60-4F0B-8AB4-BAD21D237DED.sorted_genome_alignments.bam,57,83D04848-BB60-4F0B-8AB4-BAD21D237DED,6592a7db-cbc7-4afd-9fdb-5cc16c16eeca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,7C14E252-52B9-4944-858E-479F29F156B7,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.78,48.61,RNA,,,,2010.0,Alive
s12154,FF5A0927-63F0-4DFD-9782-161738D2A5B4,UNCID_1360096.63f7a81e-c404-49fc-bc72-52b2a81ea9a5.sorted_genome_alignments.bam,39,63F7A81E-C404-49FC-BC72-52B2A81EA9A5,4fa53eb7-1fdb-4fe5-b5ad-f3d8069b3eb8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0A16FE83-515B-40BD-A335-352B794C35F3,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,10.0,0.16,1.82,9.4,RNA,,,,2010.0,Alive
s16719,A2E81869-9580-464C-BA80-C0C4F78458FA,UNCID_2081797.dff668bd-b423-4ab8-961c-93c0bc093763.sorted_genome_alignments.bam,48,DFF668BD-B423-4AB8-961C-93C0BC093763,23d8e6a0-fa79-4323-a0a6-2dea2a319667,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,E8A5EC1D-B962-4B48-8EAE-D49BD6291B6B,Alive,ILSbio,University of North Carolina,Vietnam,Hepatocellular Carcinoma,T4,N0,Stage IIIB,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.17,1.89,59.51,RNA,,,,2012.0,Alive
s9924,07C564CB-6C0F-43A8-AE76-CE998DF58001,UNCID_609732.b644b4e8-eb89-4d9f-b76b-74fd5ee79d54.111027_UNC11-SN627_0163_AC0537ABXX.7.trimmed.annotated.translated_to_genomic.bam,54,B644B4E8-EB89-4D9F-B76B-74FD5EE79D54,f2b93fbd-5848-46e2-978e-ba84e810e0dc,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,D513CFDE-B38C-4459-8A3D-36B44B80EB72,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,25.0,0.13,1.7,32.8,RNA,,,,2003.0,Alive
s10425,AA898974-5476-4A96-8EE6-7F17566FBA6D,UNCID_1077411.02311dd2-115e-452f-a5de-b3230a51d7f2.sorted_genome_alignments.bam,79,02311DD2-115E-452F-A5DE-B3230A51D7F2,f355cd59-eaa9-46c7-ab07-b90a7afc875c,274.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,918BD17A-9ED5-4C0B-8EF6-7FA4BF53579E,Dead,Roswell Park,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.1,C34.1,NO,,Not available,134.0,0.14,1.8,716.0,RNA,,,,2006.0,Dead
s8163,48068B7A-4842-4608-9EAD-5493D592F470,UNCID_1404480.ed075623-6495-4eab-a15d-ab68d5ca0999.sorted_genome_alignments.bam,33,ED075623-6495-4EAB-A15D-AB68D5CA0999,ae2db022-eb4f-4b65-89b6-9fd4439ddeef,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,4BA48810-3915-4567-9D35-615DF00006E4,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,,Not available,32.0,0.15,1.7,65.3,RNA,081E2E6C-B7B1-41AC-9EBD-6809E42764AB,Primary Tumor Field,EXTERNAL BEAM,2006.0,Alive
s5853,05B26C31-45F7-4A0C-8199-1662F32911F3,UNCID_1137697.44225bb7-92c6-4a6d-b136-bc51666ba84a.sorted_genome_alignments.bam,63,44225BB7-92C6-4A6D-B136-BC51666BA84A,f6ed684f-ee7a-496c-80d5-6eacd494d16a,,Breast Invasive Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,CAC72F1C-D337-4E20-8BA0-E48126517A66,Alive,MSKCC,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N0 (i-),Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.9,29.97,RNA,,,,2004.0,Alive
s13065,72C12362-B00E-4814-BA7B-86F67D74A5E0,UNCID_1623564.2caeddb8-47d4-4e53-bd70-17d5b2269462.sorted_genome_alignments.bam,71,2CAEDDB8-47D4-4E53-BD70-17D5B2269462,beb63625-d9bf-4ccd-bc53-635b53d24240,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,2E1B57AD-631A-4F73-92EE-06A1E5C5091F,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N2,Stage IV,Mar-40,C18.2,C18.2,NO,,Not available,155.0,0.15,1.8,290.0,RNA,,,,2009.0,Alive
s15405,1859C465-8F9E-4B93-90A4-AE9F4D170B34,TCGA-D7-6818-01A-11R-1884-13_rnaseq.bam,53,5EC73F48-D3FC-4394-96D2-3A334C3A5837,aa2934f9-8783-428e-88a6-1d04b93fa1fd,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,953E155F-D9E1-41C8-BA12-351A38195D22,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Adenocarcinoma  Diffuse Type,T2,N3,Stage IIIA,Mar-45,C16.2,C16.2,NO,,Not available,27.0,0.16,1.7,57.2,RNA,1306A26A-4FAA-4E7B-8AAC-B39F8956D369,Primary Tumor Field,EXTERNAL BEAM,2011.0,Alive
s4728,10A10AF1-C407-43D0-8C04-5B5360A47240,UNCID_2442622.87087b2e-a589-4a75-a005-2c61cb44b414.sorted_genome_alignments.bam,54,87087B2E-A589-4A75-A005-2C61CB44B414,b43de98d-4bb1-41a1-91f2-ce4e7ea4d0ca,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,3043A6C9-3DCE-4A5B-BBB1-9AD5A07F21E8,Alive,Molecular Response,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Complete Remission/Response,30.0,0.16,1.84,100.14,RNA,,,,2013.0,Alive
s12144,C10CDDE3-73E0-4214-88C1-664F67F68D43,UNCID_1254226.6a279cfe-e09e-4508-95aa-1f2f51a82bf8.sorted_genome_alignments.bam,62,6A279CFE-E09E-4508-95AA-1F2F51A82BF8,cb29e795-7618-4882-a7e0-69d39787b80c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D0A669AF-1A0A-451D-9D6F-9EEE15F7264C,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,2.0,60.16,RNA,,,,2010.0,Alive
s25,0E518E80-3774-4AC0-B5CE-30F50E46F059,UNCID_2560841.f7f581cf-3c93-4eaf-9f10-299006f058ce.sorted_genome_alignments.bam,69,F7F581CF-3C93-4EAF-9F10-299006F058CE,9d9109f5-5917-4126-8e34-8a7e4632e913,,Cholangiocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-CHOL,Illumina HiSeq,Bile Duct,WHITE,HG19,Primary Tumor,C333B64D-64B7-448F-A786-EE7B82B84B06,Alive,University of North Carolina,University of North Carolina,United States,Not available,T3,N1,Stage IVB,Mar-60,C22.1,C22.1,NO,YES,Not available,30.0,0.17,1.85,19.82,RNA,,,,,Alive
s4638,CAF2D7BD-6115-4297-B10A-8B532A2C6A57,UNCID_1614611.fffc5da3-ed33-4f8d-982e-e75b2d707c4b.sorted_genome_alignments.bam,74,FFFC5DA3-ED33-4F8D-982E-E75B2D707C4B,787d313f-9255-4b93-8ac2-0aa8febb7909,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,08F6F51F-9C99-4581-8CDA-BEC9A5208EE8,Alive,Washington University,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,2.0,79.16,RNA,,,,2009.0,Alive
s5061,7918FBE0-CA3E-4F5C-80F4-3714F8E81FE4,UNCID_1620101.4f4a8bd9-c07f-4930-8600-349ab60a37a7.sorted_genome_alignments.bam,76,4F4A8BD9-C07F-4930-8600-349AB60A37A7,9205c164-7975-421a-90c3-edfe8def595c,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,62BFF77E-4FE6-4A9F-A867-345584608E7D,Alive,Roswell Park,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.17,1.83,40.03,RNA,4D7C686B-7C92-4697-8556-D0817AAA93BB,Primary Tumor Field,IMPLANTS,2007.0,Alive
s16753,F1C4FD0B-4157-4E6B-83C2-ABCEDA3B9EAC,UNCID_2487040.64842a3f-2584-4d55-9e6c-bb976485476a.sorted_genome_alignments.bam,48,64842A3F-2584-4D55-9E6C-BB976485476A,1bcf1762-7926-45f6-a367-d45fc3af7bc3,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,DB312A8D-28B5-4828-9731-5A175EB2C517,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.16,1.86,29.79,RNA,,,,2013.0,Alive
s18042,2A77A6F4-B9CD-4C03-B3B5-38DA4CE11108,TCGA-24-1430-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,68,4C19D12E-0160-4D01-B621-65335156488B,3018efe7-13a1-47ae-a726-8fc967c73841,863.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,EB401991-7A9A-494A-8F7C-072F39E40EC2,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,153.0,0.15,1.8,574.0,RNA,,,,2000.0,Dead
s6438,5C95053A-6068-4359-BABE-1BC59E667D1D,UNCID_2611415.cca6f765-44ff-4540-a961-0a2be4e41f93.sorted_genome_alignments.bam,72,CCA6F765-44FF-4540-A961-0A2BE4E41F93,dfaabd03-2d40-4422-b210-caf112ff4229,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,097B9DD5-5617-48BA-8600-EC5A99C75A42,Alive,International Genomics Consortium,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.87,29.55,RNA,,,,2011.0,Alive
s12384,2D07EF47-3523-49C8-9F8E-64E984C3CEDA,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam,33,F90A631C-4556-43E2-8AA2-1114326B6984,8cfc2589-b0ad-4fe6-8420-8f6fe0178bcc,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,8133FCFE-ECC4-4503-B81E-00FDF6F87426,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,,51.44,DNA,,,,2011.0,Alive
s6489,4BE07FEF-CDBE-46EB-B22F-B47B503B7046,UNCID_1120519.ee8b563d-11bb-4d84-ac53-e2acc8d0275d.sorted_genome_alignments.bam,62,EE8B563D-11BB-4D84-AC53-E2ACC8D0275D,7f2a63e6-64d5-4be1-9814-e8416fc9e688,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,9BD5963E-D8F4-4EED-B32B-2EEDB00DB268,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.83,57.74,RNA,C24109D8-C044-41DF-BAF0-A3B8FC106D1B,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s10069,5C7A1BF4-D413-4EEA-899D-60DC4161BFE2,UNCID_2536906.81fd0745-ced7-4eab-adeb-0588634e1fae.sorted_genome_alignments.bam,66,81FD0745-CED7-4EAB-ADEB-0588634E1FAE,26556020-3daf-4b8b-a3de-c0532c96aca0,211.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,0193B241-1FD8-482D-BBC5-49250D9737C5,Dead,Johns Hopkins,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.1,C34.1,NO,YES,Progressive Disease,30.0,0.16,1.9,23.26,RNA,,,,2002.0,Dead
